Skip to main content
ACR Convergence 2023 Main banner
Final Program


Schedule at a Glance
Legend
Session Format
In Person
In Person
Livestreamed
Livestreamed
On Demand
On Demand

  1. Home

  • Sunday, Nov 12th
    9:00 AM – 10:00 AM PT
    12S111: Lupus Prevention and Disease-Modifying Anti-Lupus Drugs (DMALDs), Are We There Yet?
    Location: Room 11A-B
    Moderator: April Jorge, MD – Massachusetts General Hospital
    Moderator: Diane Kamen, MD, MS – Medical University of South Carolina
    Systemic lupus erythematosus (SLE)
     CME: 1 hours
  • Sunday, Nov 12th
    9:00 AM – 10:00 AM PT
    12S116: Under Pressure: Updates in Lupus Nephritis
    Location: Room 6A-B
    Moderator: Jaime Guzman, MD, MSc – University of British Columbia and BC Children's Hospital
    Moderator: Linda Hiraki, MD, FRCPC, ScD – The Hospital for Sick Children
    Systemic lupus erythematosus (SLE)
     CME: 1 hours
  • Sunday, Nov 12th
    9:00 AM – 9:15 AM PT
    Can Lupus Be Prevented?
    Location: Room 11A-B
    Speaker: David Karp, MD, PhD – UT Southwestern Medical Center
    Systemic lupus erythematosus (SLE)
  • Sunday, Nov 12th
    9:00 AM – 9:15 AM PT
    Relevance of Histology on Pediatric Lupus Nephritis Prognosis
    Location: Room 6A-B
    Speaker: Simone Appenzeller, MD, PhD – Unicamp
    Systemic lupus erythematosus (SLE)
  • Sunday, Nov 12th
    9:15 AM – 9:30 AM PT
    Diagnostic and Prognostic Biomarkers
    Location: Room 6A-B
    Speaker: Hermine Brunner, MD, MSc, MBA – Cincinnati Children's Hospital Medical Center
    Systemic lupus erythematosus (SLE)
  • Sunday, Nov 12th
    9:15 AM – 9:30 AM PT
    Disease Modification in SLE-Definition
    Location: Room 11A-B
    Systemic lupus erythematosus (SLE)
  • Sunday, Nov 12th
    9:30 AM – 9:45 AM PT
    Beyond Hypertension: Non-Immunological Therapies
    Location: Room 6A-B
    Speaker: Mark Mitsnefes, MD (he/him/his) – Cincinnati Children's Hospital Medical Center
    Systemic lupus erythematosus (SLE)
  • Sunday, Nov 12th
    9:30 AM – 9:45 AM PT
    Can Current Lupus Treatments Be Classified as DMALDs?
    Location: Room 11A-B
    Speaker: Anca Askanase, MD, MPH – Columbia University Medical Center
    Systemic lupus erythematosus (SLE)
  • Sunday, Nov 12th
    9:45 AM – 10:00 AM PT
    Q&A
    Location: Room 11A-B
    Systemic lupus erythematosus (SLE)
  • Sunday, Nov 12th
    9:45 AM – 10:00 AM PT
    Q&A
    Location: Room 6A-B
    Systemic lupus erythematosus (SLE)
  • Sunday, Nov 12th
    9:00 AM – 11:00 AM PT
    (0543–0581) SLE – Diagnosis, Manifestations, & Outcomes Poster I
    Location: Poster Hall
    Systemic lupus erythematosus (SLE)
  • Sunday, Nov 12th
    9:00 AM – 11:00 AM PT
    (0582–0608) SLE – Treatment Poster I
    Location: Poster Hall
    Systemic lupus erythematosus (SLE)
  • Sunday, Nov 12th
    9:00 AM – 11:00 AM PT
    0543: Sensitivity of the 2019 European Alliance of Associations for Rheumatology /American College of Rheumatology Classification Criteria for Systemic Lupus Erythematosus in a Population-based Cohort; A Study Set in Norway 2000-2015
    Location: Poster Hall
    Abstract Poster Presenter: Hilde Haukeland, PhD – University of Oslo
    Systemic lupus erythematosus (SLE)
  • Sunday, Nov 12th
    9:00 AM – 11:00 AM PT
    0544: Autoantibodies to dsDNA and Associated Proteins: Association with Proteinuria and Lupus Nephritis
    Location: Poster Hall
    Abstract Poster Presenter: Ranjan Gupta, MD, DM – All India Institute of Medical Sciences
    Systemic lupus erythematosus (SLE)
  • Sunday, Nov 12th
    9:00 AM – 11:00 AM PT
    0545: Referral Pattern and Factors Associated with Time to Diagnosis for Lupus in India- multicentric Data from the SLE Special Interest Group (SIG) of the Indian Rheumatology Association (IRA)
    Location: Poster Hall
    Abstract Poster Presenter: Amita Aggarwal, MD, MBBS, DM – Sanjay Gandhi Postgraduate Institute of Medical Sciences, Lucknow, India
    Systemic lupus erythematosus (SLE)
  • Sunday, Nov 12th
    9:00 AM – 11:00 AM PT
    0546: Markers of Oxidative Stress in Systemic Lupus Erythematosus Patients with Nephritis
    Location: Poster Hall
    Abstract Poster Presenter: Lu Liu, PhD (she/her/hers) – University Medical Center Groningen
    Systemic lupus erythematosus (SLE)
  • Sunday, Nov 12th
    9:00 AM – 11:00 AM PT
    0547: A Spatially-resolved Single Cell Resolution Atlas of Pediatric Lupus Nephritis Uncovers Complex Interactions Between Stromal and Infiltrating Immune Cells
    Location: Poster Hall
    Abstract Poster Presenter: Shaun Jackson, MD, PhD – Seattle Children's Research Institute
    Systemic lupus erythematosus (SLE)
  • Sunday, Nov 12th
    9:00 AM – 11:00 AM PT
    0548: Clinical and Interferon Biomarkers to Exclude Imminent Autoimmune Disease in ANA Positive Individuals
    Location: Poster Hall
    Abstract Poster Presenter: Md Yuzaiful Md Yusof, PhD, MBChB, MRCP (he/him/his) – University of Leeds
    Systemic lupus erythematosus (SLE)
  • Sunday, Nov 12th
    9:00 AM – 11:00 AM PT
    0549: Development of Customized Digital Cognitive Assessment Battery: A Pilot Use Case in SLE Patients
    Location: Poster Hall
    Abstract Poster Presenter: Liza Rajasekhar, MD, MBBS – Nizam's Institute of Medical Sciences
    Systemic lupus erythematosus (SLE)
  • Sunday, Nov 12th
    9:00 AM – 11:00 AM PT
    0550: Harnessing Machine Learning to Predict Neuropsychiatric Events in Systemic Lupus Erythematosus
    Location: Poster Hall
    Abstract Poster Presenter: Dionysis Nikolopoulos, MD – Karolinska Institutet and Karolinska University Hospital, Division of Rheumatology, Department of Medicine Solna
    Systemic lupus erythematosus (SLE)
  • Sunday, Nov 12th
    9:00 AM – 11:00 AM PT
    0551: Monogenic Lupus: Clinical Phenotypes and Genetic Mutations in a Cohort of Pediatric Patients
    Location: Poster Hall
    Abstract Poster Presenter: keerthi vardhan yerram, MD, DM (he/him/his) – Nizams institute of medical sciences
    Systemic lupus erythematosus (SLE)
  • Sunday, Nov 12th
    9:00 AM – 11:00 AM PT
    0552: The Impact of Antiphospholipid Antibodies on Future Atherosclerotic Cardiovascular Disease Risk in Systemic Lupus Erythematosus
    Location: Poster Hall
    Abstract Poster Presenter: Yu Fang Ding, MD (she/her/hers) – Peking Union Medical College
    Systemic lupus erythematosus (SLE)
  • Sunday, Nov 12th
    9:00 AM – 11:00 AM PT
    0553: Serum Isolevuglandin IgG Antibody Concentrations Are Increased in Patients with Systemic Lupus Erythematosus versus Control Subjects and Associated with Lower 24-hour Blood Pressure
    Location: Poster Hall
    Abstract Poster Presenter: Anastasiia Phothisane, MSc – Vanderbilt University Medical Center
    Systemic lupus erythematosus (SLE)
  • Sunday, Nov 12th
    9:00 AM – 11:00 AM PT
    0554: A Refined Disease Activity Immune Index Informed by Select Immune Mediators That Characterizes Clinical Disease Activity in Systemic Lupus Erythematosus
    Location: Poster Hall
    Abstract Poster Presenter: Melissa Munroe, MD, PhD (she/her/hers) – Oklahoma Medical Research Foundation
    Systemic lupus erythematosus (SLE)
  • Sunday, Nov 12th
    9:00 AM – 11:00 AM PT
    0555: Evaluation and Management of the “False Positive” ANA and Undifferentiated Connective Tissue Disease Amongst Rheumatologists
    Location: Poster Hall
    Abstract Poster Presenter: Neha Gupta, MD – Virginia Commonwealth University
    Systemic lupus erythematosus (SLE)
  • Sunday, Nov 12th
    9:00 AM – 11:00 AM PT
    0556: Classical Complement Activation in Lupus Nephritis Correlates with Disease Biomarkers: Results from Two Observational Studies
    Location: Poster Hall
    Abstract Poster Presenter: Edmund Chang, PhD – Annexon Biosciences
    Systemic lupus erythematosus (SLE)
  • Sunday, Nov 12th
    9:00 AM – 11:00 AM PT
    0557: Longitudinal Evaluation of Cell-bound Complement Activation Products in Patients with SLE
    Location: Poster Hall
    Abstract Poster Presenter: Jennifer Rogers, MD – Duke
    Systemic lupus erythematosus (SLE)
  • Sunday, Nov 12th
    9:00 AM – 11:00 AM PT
    0558: Elevated Serum Levels of S100A8/A9 Discriminate Systemic Lupus Erythematosus Patients with Cognitive Impairment from Patients Without Impairment
    Location: Poster Hall
    Abstract Poster Presenter: Carolina Munoz-Grajales, MD, PhD (she/her/hers) – UHN/TWH
    Systemic lupus erythematosus (SLE)
  • Sunday, Nov 12th
    9:00 AM – 11:00 AM PT
    0559: Development of Charlson Comorbidity Index (CCI) Comorbidities and CCI Score in Danish Nationwide Cohort of 3,178 Patients with Newly Diagnosed Systemic Lupus Erythematosus
    Location: Poster Hall
    Abstract Poster Presenter: Renata Hansen, MD – Copenhagen Research Center for Autoimmune Connective Tissue Diseases, Copenhagen University Hospital, Rigshospitalet, Denmark
    Systemic lupus erythematosus (SLE)
  • Sunday, Nov 12th
    9:00 AM – 11:00 AM PT
    0560: Genetic Determinants of Lupus Nephritis and Kidney Function in Systemic Lupus Erythematosus
    Location: Poster Hall
    Abstract Poster Presenter: Linda Hiraki, MD, FRCPC, ScD – The Hospital for Sick Children
    Systemic lupus erythematosus (SLE)
  • Sunday, Nov 12th
    9:00 AM – 11:00 AM PT
    0561: Frequency of Anti-Ro Antibodies in Systemic Lupus Erythematosus Patients: Insights from Multicenter and National Registry
    Location: Poster Hall
    Abstract Poster Presenter: Lucia Mendoza Martinez, APRN (she/her/hers) – Hospital General de Agudos Dr. Enrique Tornú
    Systemic lupus erythematosus (SLE)
  • Sunday, Nov 12th
    9:00 AM – 11:00 AM PT
    0562: HDL-Cholesterol Efflux and the Complement System Are Linked in Systemic Lupus Erythematosus
    Location: Poster Hall
    Abstract Poster Presenter: IVAN FERRAZ AMARO, MD – Hospital Universitario de Canarias
    Systemic lupus erythematosus (SLE)
  • Sunday, Nov 12th
    9:00 AM – 11:00 AM PT
    0563: Urinary Neutrophil Gelatinase-associated Lipocalin (NGAL) as a Mediator of the Association Between Particulate Matter Exposure and Disease Activity in Systemic Lupus Erythematosus
    Location: Poster Hall
    Abstract Poster Presenter: Ji-Hyoun Kang, MD – Chonnam National University Hospital
    Systemic lupus erythematosus (SLE)
  • Sunday, Nov 12th
    9:00 AM – 11:00 AM PT
    0564: Risk Factors for Immune Thrombocytopenia in Systemic Lupus Erythematosus and Generation of a Predictive Model to Assess Its Risk of Development
    Location: Poster Hall
    Abstract Poster Presenter: Irene Carrión-Barberà, MD – Hospital del Mar
    Systemic lupus erythematosus (SLE)
  • Sunday, Nov 12th
    9:00 AM – 11:00 AM PT
    0565: Insulin Resistance and the Complement System Are Linked in Patients with Systemic Lupus Erythematosus
    Location: Poster Hall
    Abstract Poster Presenter: Jose María Viotti Serra, MD (he/him/his) – Hospital Universitario de Canarias
    Systemic lupus erythematosus (SLE)
  • Sunday, Nov 12th
    9:00 AM – 11:00 AM PT
    0566: Characterization of Disease Activity Using a Novel Physiologic Biomarker in Pediatric SLE
    Location: Poster Hall
    Abstract Poster Presenter: Sangeeta Sule, MD, PhD (she/her/hers) – Children's National Hospital
    Systemic lupus erythematosus (SLE)
  • Sunday, Nov 12th
    9:00 AM – 11:00 AM PT
    0567: N-Terminal Pro-Brain Natriuretic Peptide Correlates Strongly with Cardiovascular Damage in Systemic Lupus Erythematous (SLE): A Cross-sectional Study
    Location: Poster Hall
    Abstract Poster Presenter: Arielle Mendel, MD, FRCPC, MSc – McGill University Health Centre
    Systemic lupus erythematosus (SLE)
  • Sunday, Nov 12th
    9:00 AM – 11:00 AM PT
    0568: Comparison of Plasma Protein Profiles and Endothelial Function in Patients with Pediatric-Onset Systemic Lupus Erythematosus and Healthy Controls
    Location: Poster Hall
    Abstract Poster Presenter: Liyoung Kim, MD – Boston Children's Hospital
    Systemic lupus erythematosus (SLE)
  • Sunday, Nov 12th
    9:00 AM – 11:00 AM PT
    0569: Serum S100A8 and S100A9 Are Useful Biomarker Indicated IFN Associated Organ Involvements in Systemic Lupus Erythematosus
    Location: Poster Hall
    Abstract Poster Presenter: Risa Wakiya, MD, PhD – Division of Hematology, Rheumatology and Respiratory Medicine, Department of Internal Medicine, Faculty of Medicine, Kagawa University
    Systemic lupus erythematosus (SLE)
  • Sunday, Nov 12th
    9:00 AM – 11:00 AM PT
    0570: BLyS Levels Are Elevated in Systemic Lupus Erythematosus Patients with Neuropsychiatric Manifestations
    Location: Poster Hall
    Abstract Poster Presenter: Simone Appenzeller, MD, PhD – Unicamp
    Systemic lupus erythematosus (SLE)
  • Sunday, Nov 12th
    9:00 AM – 11:00 AM PT
    0571: A Polygenic Risk Score for Systemic Lupus Erythematosus (SLE) Discriminates Between Patients with Lupus and Individuals Without Lupus and a Positive Antinuclear Antibody Test
    Location: Poster Hall
    Abstract Poster Presenter: Cecilia Chung, MD, MPH – University of Miami
    Systemic lupus erythematosus (SLE)
  • Sunday, Nov 12th
    9:00 AM – 11:00 AM PT
    0572: Serum/ Urine Levels and Expression of CD163 in Lupus Nephritis
    Location: Poster Hall
    Abstract Poster Presenter: Erdem Gürel, MD – Istanbul Faculty of Medicine, Istanbul University
    Systemic lupus erythematosus (SLE)
  • Sunday, Nov 12th
    9:00 AM – 11:00 AM PT
    0573: Presence of Mediterranean Fever Gene Variants Provides Protection from the Development of Lupus Nephritis in Patients with Systemic Lupus Erythematosus
    Location: Poster Hall
    Abstract Poster Presenter: Yushiro Endo, MD, PhD – Department of Immunology and Rheumatology, Division of Advanced Preventive Medical Sciences, Nagasaki University Graduate School of Biomedical Sciences
    Systemic lupus erythematosus (SLE)
  • Sunday, Nov 12th
    9:00 AM – 11:00 AM PT
    0574: WITHDRAWN
    Location: Poster Hall
    Systemic lupus erythematosus (SLE)
  • Sunday, Nov 12th
    9:00 AM – 11:00 AM PT
    0575: The Real-World Utility of a Lupus Activity Monitoring Panel in the United States Community Rheumatologist Practice
    Location: Poster Hall
    Abstract Poster Presenter: Andrew Concoff, MD – Exagen, Inc.
    Systemic lupus erythematosus (SLE)
  • Sunday, Nov 12th
    9:00 AM – 11:00 AM PT
    0576: Enhancing Systemic Lupus Erythematosus Diagnosis: Comparative Performance Characteristics of TC4d and Anti-T-Cell Antibodies with Conventional Biomarkers
    Location: Poster Hall
    Abstract Poster Presenter: Andrew Concoff, MD – Exagen, Inc.
    Systemic lupus erythematosus (SLE)
  • Sunday, Nov 12th
    9:00 AM – 11:00 AM PT
    0577: Analysis of Intracytoplasmic Toll - Like Receptors (TLRs) and MyD88 Expression in B Cell Subsets in Patients with Lupus Nephritis
    Location: Poster Hall
    Abstract Poster Presenter: Michelle Patricia Loeza Uribe, MD (she/her/hers) – Instituto Nacional de Ciencias Médicas y Nutrición, Salvador Zubirán.
    Systemic lupus erythematosus (SLE)
  • Sunday, Nov 12th
    9:00 AM – 11:00 AM PT
    0578: Prospective Observational Study of Microvascular C5b-9 Deposition in Non-lesional Skin in Systemic Lupus Erythematosus Patients and Its Correlation with Active Lupus Nephritis
    Location: Poster Hall
    Abstract Poster Presenter: Meghan Anderson, DO (she/her/hers) – University of Pennsylvania
    Systemic lupus erythematosus (SLE)
  • Sunday, Nov 12th
    9:00 AM – 11:00 AM PT
    0579: Sub-types of Ischemic Stroke in Systemic Lupus Erythematosus,-associations with STAT4 and HLA-DRB1 Risk Genotypes
    Location: Poster Hall
    Abstract Poster Presenter: Elisabet Svenungsson, MD – Karolinska Institutet
    Systemic lupus erythematosus (SLE)
  • Sunday, Nov 12th
    9:00 AM – 11:00 AM PT
    0580: Performance of Conventional Cardiovascular Risk Scores in Identifying Subclinical Atherosclerosis in Systemic Lupus Erythematosus
    Location: Poster Hall
    Abstract Poster Presenter: Chengappa Kavadichanda, MD, DM – Jawaharlal Institute of Postgraduate Medical Education and Research
    Systemic lupus erythematosus (SLE)
  • Sunday, Nov 12th
    9:00 AM – 11:00 AM PT
    0581: Performance Characteristics of a Novel, Fully Automated Multiplexed Immunoassay Microarray Prototype for the Serological Detection of Eleven IgG Autoantibodies Commonly Found in Connective Tissue Diseases
    Location: Poster Hall
    Abstract Poster Presenter: Gerber Gomez, MD, MSc – Quotient Suisse SA
    Systemic lupus erythematosus (SLE)
  • Sunday, Nov 12th
    9:00 AM – 11:00 AM PT
    0582: Evaluation of Anifrolumab Treatment Responses by the Short Form 36 Health Survey Version 2 in SLE: A Post Hoc Analysis of the Placebo-Controlled Phase 3 Long-Term Extension Trial
    Location: Poster Hall
    Abstract Poster Presenter: Vibeke Strand, MD, FACP, MACR – Stanford University School of Medicine, Palo Alto CA
    Systemic lupus erythematosus (SLE)
  • Sunday, Nov 12th
    9:00 AM – 11:00 AM PT
    0583: Therapeutic Potential of Imvotamab, a CD20-Targeted Bispecific IgM T Cell Engager, for the Treatment of Refractory Autoimmune Disease Patients
    Location: Poster Hall
    Abstract Poster Presenter: Racquel Domingo-Gonzalez, PhD (she/her/hers) – IGM Biosciences
    Systemic lupus erythematosus (SLE)
  • Sunday, Nov 12th
    9:00 AM – 11:00 AM PT
    0584: Targeting Key Components of SLE Pathogenesis with the Multifaceted Immunomodulatory Properties of Cenerimod, a Selective S1P1 Receptor Modulator
    Location: Poster Hall
    Abstract Poster Presenter: Marianne Martinic, PhD – Idorsia Pharmaceuticals Ltd.
    Systemic lupus erythematosus (SLE)
  • Sunday, Nov 12th
    9:00 AM – 11:00 AM PT
    0586: Therapeutic Drug Monitoring of Azathioprine and Tacrolimus in SLE Pregnancies: Preliminary Results from the LEGACY Cohort
    Location: Poster Hall
    Abstract Poster Presenter: Arielle Mendel, MD, FRCPC, MSc – McGill University Health Centre
    Systemic lupus erythematosus (SLE)
  • Sunday, Nov 12th
    9:00 AM – 11:00 AM PT
    0587: Impact of up to 24 Months Intravenous (IV) Belimumab (BEL) Treatment on Steroid Use and Disease Activity in Patients with SLE in Clinical Practice: Additional Post Hoc Pooled Analysis of Multicountry OBSErve Cohort Data
    Location: Poster Hall
    Abstract Poster Presenter: Roger Abramino Levy, MD, PhD – GSK
    Systemic lupus erythematosus (SLE)
  • Sunday, Nov 12th
    9:00 AM – 11:00 AM PT
    0588: Long Term Safety and Predictors of Serious Infections Among Patients with Systemic Lupus Erythematosus Treated with Rituximab: Audit from a Single Center Biologic Registry
    Location: Poster Hall
    Abstract Poster Presenter: Augustine Jose, MD (he/him/his) – Jawaharlal Institute of Postgraduate Medical Education and Research
    Systemic lupus erythematosus (SLE)
  • Sunday, Nov 12th
    9:00 AM – 11:00 AM PT
    0589: A Comparative Evaluation of IgA2 Anti-dsDNA Antibodies and Clinical Outcome in Two Clinical Trials of Belimumab After Rituximab in SLE
    Location: Poster Hall
    Abstract Poster Presenter: Muhammad RA Shipa, MBBS, MRCP (he/him/his) – University College London
    Systemic lupus erythematosus (SLE)
  • Sunday, Nov 12th
    9:00 AM – 11:00 AM PT
    0590: Comparing Safety and Efficacy of Sodium-Glucose Co-Transporter 2 Inhibitors versus Dipeptidyl Peptidase 4 Inhibitors in Patients with Systemic Lupus Erythematosus and Comorbid Type 2 Diabetes Mellitus
    Location: Poster Hall
    Abstract Poster Presenter: Jui-En Lo, MD – UC San Diego
    Systemic lupus erythematosus (SLE)
  • Sunday, Nov 12th
    9:00 AM – 11:00 AM PT
    0591: Despite Dramatic Expansion of Approved Biologics in SLE, Unmet Needs Remain
    Location: Poster Hall
    Abstract Poster Presenter: Ryan Rex, BS – Spherix Global Insights
    Systemic lupus erythematosus (SLE)
  • Sunday, Nov 12th
    9:00 AM – 11:00 AM PT
    0592: Real-World Treatment Patterns in Patients with Systemic Lupus Erythematosus: An Analysis of the SLE Prospective Observational Cohort Study (SPOCS)
    Location: Poster Hall
    Abstract Poster Presenter: Martin Aringer, MD – University Medical Center and Faculty of Medicine TU Dresden
    Systemic lupus erythematosus (SLE)
  • Sunday, Nov 12th
    9:00 AM – 11:00 AM PT
    0593: Lupus Nephritis of the Spanish National Registry of Belimumab in Patients with Systemic Lupus Erythematosus
    Location: Poster Hall
    Abstract Poster Presenter: Vicente Aldasoro Caceres, MD – Hospital Universitario de Navarra
    Systemic lupus erythematosus (SLE)
  • Sunday, Nov 12th
    9:00 AM – 11:00 AM PT
    0594: Baseline Innate Immunity Transcriptional Signatures Act as Predictors of Response to Immunosuppressive and Biologic Treatments in Systemic Lupus Erythematosus While Disturbances Linked to p53-signaling Define “Resistant” Disease
    Location: Poster Hall
    Abstract Poster Presenter: Panagiotis Garantziotis, MD, PhD (he/him/his) – Department of Internal Medicine 3-Rheumatology and Immunology, Friedrich-Alexander-University Erlangen-Nürnberg, Erlangen, Germany
    Systemic lupus erythematosus (SLE)
  • Sunday, Nov 12th
    9:00 AM – 11:00 AM PT
    0595: Renal Involvement in Patients with Systemic Lupus Erythematosus Treated with Anifrolumab Compared with Placebo over a 4-Year Period
    Location: Poster Hall
    Abstract Poster Presenter: Richard Furie, MD – Northwell Health
    Systemic lupus erythematosus (SLE)
  • Sunday, Nov 12th
    9:00 AM – 11:00 AM PT
    0596: Deucravacitinib, an Oral, Selective, Allosteric Tyrosine Kinase 2 Inhibitor, in a Phase 2 Trial in Systemic Lupus Erythematosus (SLE): Achievement of Sustained SRI(4), BICLA and Dual Responses over 48 Weeks
    Location: Poster Hall
    Abstract Poster Presenter: Richard Furie, MD – Northwell Health
    Systemic lupus erythematosus (SLE)
  • Sunday, Nov 12th
    9:00 AM – 11:00 AM PT
    0597: Efficacy of Anifrolumab in Systemic Lupus Erythematosus by Overall and Organ-Specific SLEDAI-2K Improvements: Results from the Randomized, Placebo-Controlled Phase 3 Long-Term Extension Study
    Location: Poster Hall
    Abstract Poster Presenter: Richard Furie, MD – Northwell Health
    Systemic lupus erythematosus (SLE)
  • Sunday, Nov 12th
    9:00 AM – 11:00 AM PT
    0598: Litifilimab Modulates Type I IFN Biomarkers in Patients with SLE or CLE in the Phase 2 LILAC Study
    Location: Poster Hall
    Abstract Poster Presenter: Richard Furie, MD – Northwell Health
    Systemic lupus erythematosus (SLE)
  • Sunday, Nov 12th
    9:00 AM – 11:00 AM PT
    0599: Targeted Inhibition of Cathepsins Limits the Intracellular Complement Activation in Lupus Nephritis Podocytes
    Location: Poster Hall
    Abstract Poster Presenter: Ana Kunzler, MD (she/her/hers) – Beth Israel Deaconess Medical Center
    Systemic lupus erythematosus (SLE)
  • Sunday, Nov 12th
    9:00 AM – 11:00 AM PT
    0600: Identification of Subsets of SLE Patients Responsive to Baricitinib by Transcriptomic Analysis at Baseline
    Location: Poster Hall
    Abstract Poster Presenter: Prathyusha Bachali, MS – AMPEL BioSolutions
    Systemic lupus erythematosus (SLE)
  • Sunday, Nov 12th
    9:00 AM – 11:00 AM PT
    0601: Selective Disposition of Voclosporin, Cyclosporine, and Tacrolimus in Renal Tissue
    Location: Poster Hall
    Abstract Poster Presenter: simon Zhou, PhD – Aurinia Pharma
    Systemic lupus erythematosus (SLE)
  • Sunday, Nov 12th
    9:00 AM – 11:00 AM PT
    0602: Dual Blockade of ICOS and CD28 with Acazicolcept (ALPN-101) Reveals Non-Redundant Roles of T Cell Co-Stimulation Pathways in Systemic Lupus Erythematosus
    Location: Poster Hall
    Abstract Poster Presenter: Elizabeth Repash, BSc, MSc – Alpine Immune Sciences, Inc.
    Systemic lupus erythematosus (SLE)
  • Sunday, Nov 12th
    9:00 AM – 11:00 AM PT
    0604: Is Belimumab Dose Optimization Possible in Patients with Systemic Lupus Erythematosus?: Analysis of This Therapeutic Strategy in a Large Multicenter Cohort of Patients from Spanish Rheumatology Departments
    Location: Poster Hall
    Abstract Poster Presenter: Irene Altabas Gonzalez, MD – Complejo Hospitalario de Vigo
    Systemic lupus erythematosus (SLE)
  • Sunday, Nov 12th
    9:00 AM – 11:00 AM PT
    0605: Determining the ECG Cut-off Point in Systemic Lupus Erythematosus Patients Undergoing Hydroxychloroquine Therapy
    Location: Poster Hall
    Abstract Poster Presenter: Carmen Lasa Teja, MD – Hospital Universitario Marqués de Valdecilla
    Systemic lupus erythematosus (SLE)
  • Sunday, Nov 12th
    9:00 AM – 11:00 AM PT
    0606: Risk of Damage Progression with Belimumab versus Oral Immunosuppressant Use in Patients with Systemic Lupus Erythematosus
    Location: Poster Hall
    Abstract Poster Presenter: April Jorge, MD – Massachusetts General Hospital
    Systemic lupus erythematosus (SLE)
  • Sunday, Nov 12th
    9:00 AM – 11:00 AM PT
    0607: CAR T Cell Therapy Leads to Long-term Abrogation of Autoimmunity in SLE Patients While Vaccination Responses Are Maintained
    Location: Poster Hall
    Abstract Poster Presenter: Georg Schett, MD – Friedrich-Alexander-Universität Erlangen-Nürnberg
    Systemic lupus erythematosus (SLE)
  • Sunday, Nov 12th
    9:00 AM – 11:00 AM PT
    0608: Efficacy of Cenerimod in Patients with High IFN-1 Gene Expression Signature and High Anti-dsDNA Antibody Levels: Post-hoc Analysis from a Phase 2 Study
    Location: Poster Hall
    Abstract Poster Presenter: Anca Askanase, MD, MPH – Columbia University Medical Center
    Systemic lupus erythematosus (SLE)
  • Sunday, Nov 12th
    11:30 AM – 11:40 AM PT
    0723: Investigating the Effects and Molecular Mechanisms of TRAF5 on the Pathogenesis of SLE Associated Pulmonary Arterial Hypertension
    Location: Exhibit Hall A-B
    Plenary Presenter: Xiaoyue Deng, PhD – Peking Union Medical College Hospital
    Systemic lupus erythematosus (SLE)
  • Sunday, Nov 12th
    12:00 PM – 1:00 PM PT
    12S125: Interventions to Increase Minority Participation in Lupus Clinical Trials
    Location: Room 23A-C
    Moderator: Rosalind Ramsey-Goldman, MD, DrPH – Northwestern University
    Moderator: Kimberly Trotter, MD – University of Chicago
    Systemic lupus erythematosus (SLE)
     CME: 1 hours
  • Sunday, Nov 12th
    12:00 PM – 12:20 PM PT
    Practical Programs to Engage Diverse Participants in Lupus Clinical Trials
    Location: Room 23A-C
    Speaker: Saira Sheikh, MD – University of North Carolina at Chapel Hill
    Systemic lupus erythematosus (SLE)
  • Sunday, Nov 12th
    12:20 PM – 12:30 PM PT
    Q&A
    Location: Room 23A-C
    Systemic lupus erythematosus (SLE)
  • Sunday, Nov 12th
    12:30 PM – 12:50 PM PT
    The Impact of the Diversification of the Biomedical Workforce
    Location: Room 23A-C
    Speaker: Irene Blanco, MD, MS – Northwestern University
    Systemic lupus erythematosus (SLE)
  • Sunday, Nov 12th
    12:50 PM – 1:00 PM PT
    Q&A
    Location: Room 23A-C
    Systemic lupus erythematosus (SLE)
  • Sunday, Nov 12th
    2:00 PM – 3:30 PM PT
    12S148: Abstracts: SLE – Treatment I: Renal (0781–0786)
    Location: Ballroom 20D
    Abstract Moderator: April Jorge, MD – Massachusetts General Hospital
    Abstract Moderator: Diane Kamen, MD, MS – Medical University of South Carolina
    Systemic lupus erythematosus (SLE)
  • Sunday, Nov 12th
    2:00 PM – 2:10 PM PT
    0781: Low vs. High Initial Oral Glucocorticoid Dose for Lupus Nephritis Induction Treatment: A Pooled Analysis of Randomized Controlled Clinical Trials
    Location: Ballroom 20D
    Presenting Author: Amit Saxena, MD – NYU School of Medicine
    Systemic lupus erythematosus (SLE)
  • Sunday, Nov 12th
    2:15 PM – 2:25 PM PT
    0782: Comparison of Dual-immunosuppressive Therapy with a Voclosporin-based, Triple-immunosuppressive Regimen for Lupus Nephritis in the ALMS and AURORA 1 Studies
    Location: Ballroom 20D
    Presenting Author: Maria Dall'Era, MD (she/her/hers) – UCSF
    Systemic lupus erythematosus (SLE)
  • Sunday, Nov 12th
    2:30 PM – 2:40 PM PT
    0783: Tolerability of CAR T Cell Therapy in Autoimmune Disease
    Location: Ballroom 20D
    Presenting Author: Jule Taubmann, MD, BSc – Universitätsklinikum Erlangen
    Systemic lupus erythematosus (SLE)
  • Sunday, Nov 12th
    2:45 PM – 2:55 PM PT
    0784: Kidney-Related Outcomes and Steroid-Sparing Effects in Patients with Active Lupus Nephritis Treated with Obinutuzumab: A Post Hoc Analysis of a Phase 2 Trial
    Location: Ballroom 20D
    Presenting Author: Brad Rovin, MD – The Ohio State University
    Systemic lupus erythematosus (SLE)
  • Sunday, Nov 12th
    3:00 PM – 3:10 PM PT
    0785: Therapeutic Range of Hydroxychloroquine Blood Levels May Reduce Odds of High Lupus Disease Activity
    Location: Ballroom 20D
    Presenting Author: Shivani Garg, MD, MS – University of Madison, School of Medicine and Public Health
    Systemic lupus erythematosus (SLE)
  • Sunday, Nov 12th
    3:15 PM – 3:25 PM PT
    0786: A Retrospective Analysis of the Efficacy of the Euro-Lupus Nephritis Cyclophosphamide Regimen versus NIH Regimen in a South Carolina Lupus Nephritis Cohort
    Location: Ballroom 20D
    Presenting Author: Anna Arar, MS, BS – Medical University of South Carolina
    Systemic lupus erythematosus (SLE)
  • Sunday, Nov 12th
    4:00 PM – 5:30 PM PT
    12S167: Abstracts: SLE – Diagnosis, Manifestations, & Outcomes I: Biomarkers (0847–0852)
    Location: Exhibit Hall A-B
    Abstract Moderator: Kenneth Kalunian, MD, FACR – UC San Diego
    Abstract Moderator: May Choi, MD, FRCPC, MPH – University of Calgary
    Systemic lupus erythematosus (SLE)
  • Sunday, Nov 12th
    4:00 PM – 4:10 PM PT
    0847: Development of an IFN 5-Gene Signature Score to Identify IFN-high and IFN-low Subsets and as a Pharmacodynamic Biomarker for Deucravacitinib Treatment in a Phase 2 Trial in Patients with Systemic Lupus Erythematosus
    Location: Exhibit Hall A-B
    Presenting Author: Ian Catlett, PhD – Bristol Meyers Squibb
    Systemic lupus erythematosus (SLE)
  • Sunday, Nov 12th
    4:15 PM – 4:25 PM PT
    0848: Performance of Serum MRP8/14, sCD14, IL-6 and Neutrophil CD64 in Isolation and in Combination for Differentiating Flare from Bacterial Infection in Febrile SLE Patients
    Location: Exhibit Hall A-B
    Presenting Author: Amita Aggarwal, MD, MBBS, DM – Sanjay Gandhi Postgraduate Institute of Medical Sciences, Lucknow, India
    Systemic lupus erythematosus (SLE)
  • Sunday, Nov 12th
    4:30 PM – 4:40 PM PT
    0849: Multiplex Profiling and Machine Learning Reveal Distinct Signatures of Circulating Cytokines Associated with Autoantibody Profiles and Disease Severity in Systemic Lupus Erythematosus
    Location: Exhibit Hall A-B
    Presenting Author: Sarit Pattanaik, MD, DM – SCB Medical College and Hospital, Cuttack, Odisha
    Systemic lupus erythematosus (SLE)
  • Sunday, Nov 12th
    4:45 PM – 4:55 PM PT
    0850: Persistence of Urinary Biomarkers of Intrarenal Inflammation Precedes Loss of Kidney Function in Lupus Nephritis
    Location: Exhibit Hall A-B
    Presenting Author: Andrea Fava, MD – Johns Hopkins University
    Systemic lupus erythematosus (SLE)
  • Sunday, Nov 12th
    5:00 PM – 5:10 PM PT
    0851: Lupus Nephritis Flares Linked to Platelet Activation During Gut Pathobiont Blooms
    Location: Exhibit Hall A-B
    Presenting Author: Abhimanyu Amarnani, MD, PhD – NYU Langone Medical Center
    Systemic lupus erythematosus (SLE)
  • Sunday, Nov 12th
    5:15 PM – 5:25 PM PT
    0852: Screening for Specific Antinuclear Antibodies Using an Artificial Intelligence-enabled Antinuclear Antibody HEp-2 Substrate by Indirect Immunofluorescence Assay
    Location: Exhibit Hall A-B
    Presenting Author: Ali Duarte-Garcia, MD, MSc – Mayo Clinic
    Systemic lupus erythematosus (SLE)
  • Monday, Nov 13th
    7:30 AM – 8:30 AM PT
    13M104: Meet the Panel: The Latest in Lupus Treatment
    Location: Room 6A-B
    Moderator: Karen Costenbader, MD, MPH – Brigham and Women's Hospital/ Harvard Medical School
    Moderator: April Jorge, MD – Massachusetts General Hospital
    Systemic lupus erythematosus (SLE)
     CME: 1 hours
  • Monday, Nov 13th
    7:30 AM – 8:15 AM PT
    Meet the Panel: The Latest in Lupus Treatment
    Location: Room 6A-B
    Panelist: Maria Dall'Era, MD (she/her/hers) – UCSF
    Panelist: Richard Furie, MD – Northwell Health
    Panelist: Marta Mosca, MD, PhD – University of Pisa
    Systemic lupus erythematosus (SLE)
  • Monday, Nov 13th
    8:15 AM – 8:30 AM PT
    Q&A
    Location: Room 6A-B
    Systemic lupus erythematosus (SLE)
  • Monday, Nov 13th
    9:00 AM – 11:00 AM PT
    (0886–0898) SLE – Animal Models Poster
    Location: Poster Hall
    Systemic lupus erythematosus (SLE)
  • Monday, Nov 13th
    9:00 AM – 11:00 AM PT
    (0899–0933) SLE – Etiology & Pathogenesis Poster
    Location: Poster Hall
    Systemic lupus erythematosus (SLE)
  • Monday, Nov 13th
    9:00 AM – 11:00 AM PT
    (1442–1487) SLE – Diagnosis, Manifestations, & Outcomes Poster II
    Location: Poster Hall
    Systemic lupus erythematosus (SLE)
  • Monday, Nov 13th
    9:00 AM – 11:00 AM PT
    (1488–1512) SLE – Treatment Poster II
    Location: Poster Hall
    Systemic lupus erythematosus (SLE)
  • Monday, Nov 13th
    9:00 AM – 11:00 AM PT
    0886: Neonatal Roseolovirus Infection Predisposes to Development of Lupus-like Disease After TLR7 Stimulation
    Location: Poster Hall
    Abstract Poster Presenter: Tarin Bigley, MD, PhD – Washington University in St. Louis
    Systemic lupus erythematosus (SLE)
  • Monday, Nov 13th
    9:00 AM – 11:00 AM PT
    0887: Dapagliflozin Modulates Inflammation and Germinal Centers in Lupus by Increasing Regulatory T Cells
    Location: Poster Hall
    Abstract Poster Presenter: Javier Rangel-Moreno, PhD – University of Rochester
    Systemic lupus erythematosus (SLE)
  • Monday, Nov 13th
    9:00 AM – 11:00 AM PT
    0888: Functionally Selective Immunomodulator Shows Robust Efficacy in Spontaneous Lupus Mouse Model
    Location: Poster Hall
    Abstract Poster Presenter: Annegret Van der Aa, PhD – Ermium Therapeutics SAS
    Systemic lupus erythematosus (SLE)
  • Monday, Nov 13th
    9:00 AM – 11:00 AM PT
    0889: Axl Receptor Tyrosine Kinase Ameliorates Pristane Induced Diffuse Alveolar Hemorrhage in Mice by Regulating Macrophage Polarization
    Location: Poster Hall
    Abstract Poster Presenter: Wenwen Pei, PhD – Peking university
    Systemic lupus erythematosus (SLE)
  • Monday, Nov 13th
    9:00 AM – 11:00 AM PT
    0890: Specificity of Brain-Intrinsic and Hematopoietic-Derived Mechanisms in Mediating Neuropsychiatric Symptoms of Systemic Lupus Erythematosus
    Location: Poster Hall
    Abstract Poster Presenter: Carla Cuda, PhD – Northwestern University
    Systemic lupus erythematosus (SLE)
  • Monday, Nov 13th
    9:00 AM – 11:00 AM PT
    0891: Selective and Potent Inhibition of Cyclic GMP-AMP Synthase (cGAS) Fully Normalizes Autoinflammation Across Tissues in a Trex1-/- Mouse Model for Type I Interferonopathies
    Location: Poster Hall
    Abstract Poster Presenter: Zuzana Licenikova Horejsi, PhD – Institute of Organic Chemistry and Biochemistry of the CAS
    Systemic lupus erythematosus (SLE)
  • Monday, Nov 13th
    9:00 AM – 11:00 AM PT
    0892: Single-Cell RNA Sequencing Reveals Keratinocytes and Fibroblasts Drive Hippo and TGFb Dysregulation and Fibrosis in Epidermal Overexpression of VGLL3 in Cutaneous Lupus
    Location: Poster Hall
    Abstract Poster Presenter: Mehrnaz Gharaee-Kermani, PhD, MPH, DVM (she/her/hers) – University of Michigan
    Systemic lupus erythematosus (SLE)
  • Monday, Nov 13th
    9:00 AM – 11:00 AM PT
    0893: Involvement of Type I Interferon-responsive Myeloid Cells in Renal Inflammation in a Lupus Mouse Model
    Location: Poster Hall
    Abstract Poster Presenter: Lindsey Han – Lerner Research Institute, Cleveland Clinic Foundation
    Systemic lupus erythematosus (SLE)
  • Monday, Nov 13th
    9:00 AM – 11:00 AM PT
    0894: The Cellular and Spatial Type I Interferon Response Following Skin Exposure to Ultraviolet Light
    Location: Poster Hall
    Abstract Poster Presenter: Jie An, PhD – University of Washington
    Systemic lupus erythematosus (SLE)
  • Monday, Nov 13th
    9:00 AM – 11:00 AM PT
    0895: Lipocalin-2 Promotes Cutaneous and Neuropsychiatric Disease in Murine Lupus
    Location: Poster Hall
    Abstract Poster Presenter: Sayra Garcia, MS, BS – Albert Einstein College of Medicine
    Systemic lupus erythematosus (SLE)
  • Monday, Nov 13th
    9:00 AM – 11:00 AM PT
    0896: Targeting Toll-Like Receptor 7 with DS-7011a, a Promising Novel Antagonistic Antibody for the Treatment of Systemic Lupus Erythematosus
    Location: Poster Hall
    Abstract Poster Presenter: ATSUSHI MANNO, PhD (he/him/his) – Daiichi Sankyo Co., Ltd.
    Systemic lupus erythematosus (SLE)
  • Monday, Nov 13th
    9:00 AM – 11:00 AM PT
    0897: Steroid-sparing Effects of Afimetoran (BMS-986256), an Equipotent Toll-like Receptor (TLR)7 and TLR8 Antagonist, in a Lupus Mouse Model
    Location: Poster Hall
    Abstract Poster Presenter: ALARIC DYCKMAN, PhD – Bristol Myers Squibb
    Systemic lupus erythematosus (SLE)
  • Monday, Nov 13th
    9:00 AM – 11:00 AM PT
    0898: The Role of the Endothelin System in the Development of TLR7-accelerated Lupus-Associated Cardiac Dysfunction
    Location: Poster Hall
    Abstract Poster Presenter: Kennedy Hawkins, BS – MUSC
    Systemic lupus erythematosus (SLE)
  • Monday, Nov 13th
    9:00 AM – 11:00 AM PT
    0899: Complement Factor I (CFI) Gene Expression by Kidney Tubular Cells Is Increased in Lupus Nephritis Patients with Interstitial Fibrosis and Tubular Atrophy
    Location: Poster Hall
    Abstract Poster Presenter: Shudan Wang, MD, MS – Albert Einstein College of Medicine
    Systemic lupus erythematosus (SLE)
  • Monday, Nov 13th
    9:00 AM – 11:00 AM PT
    0900: Complement Deposition on Extracellular Mitochondria Induces Platelet Activation in Vitro
    Location: Poster Hall
    Abstract Poster Presenter: Marina Barguil Macedo, MD, MS – University of Washington
    Systemic lupus erythematosus (SLE)
  • Monday, Nov 13th
    9:00 AM – 11:00 AM PT
    0901: Scavenging of Isolevuglandins Attenuates Neutrophil Expansion and Aortic NETosis in Systemic Lupus Erythematosus
    Location: Poster Hall
    Abstract Poster Presenter: David Patrick, MD, PhD – Vanderbilt University Medical Center
    Systemic lupus erythematosus (SLE)
  • Monday, Nov 13th
    9:00 AM – 11:00 AM PT
    0902: Neutrophils in Systemic Lupus Erythematosus Demonstrate Heterogeneity Based on Sex
    Location: Poster Hall
    Abstract Poster Presenter: William Ambler, MD (he/him/his) – Systemic Autoimmunity Branch, National Institute of Arthritis and Musculoskeletal and Skins Diseases, National Institutes of Health
    Systemic lupus erythematosus (SLE)
  • Monday, Nov 13th
    9:00 AM – 11:00 AM PT
    0903: Effects of Hydroxychloroquine on Maternal Outcomes in Pregnant Patients with Systemic Lupus Erythematous
    Location: Poster Hall
    Abstract Poster Presenter: Yurilu Gonzalez Moret, MD (she/her/hers) – Albert Einstein Medical Center
    Systemic lupus erythematosus (SLE)
  • Monday, Nov 13th
    9:00 AM – 11:00 AM PT
    0904: KYV-101, a Fully Human Anti-CD19 CAR T Cell Therapy, Demonstrates CAR-Mediated and CD19-Dependent Activity Against Autologous B Cells from Patients with Autoimmune Disease
    Location: Poster Hall
    Abstract Poster Presenter: Tom Van Blarcom, PhD – Kyverna Therapuetics
    Systemic lupus erythematosus (SLE)
  • Monday, Nov 13th
    9:00 AM – 11:00 AM PT
    0905: Low-Density Granulocytes and Neutrophil Extracellular Traps in Incomplete Systemic Lupus Erythematosus
    Location: Poster Hall
    Abstract Poster Presenter: Svenja Henning, MD (she/her/hers) – University of Groningen
    Systemic lupus erythematosus (SLE)
  • Monday, Nov 13th
    9:00 AM – 11:00 AM PT
    0906: Paired Autoantibody Specificities from Serum and Immune Complexes Do Not Fully Explain the Circulating Immune Complex Load in Systemic Lupus Erythematosus: A Study on 530 Patients
    Location: Poster Hall
    Abstract Poster Presenter: Enrico Fuzzi, MD – Karolinska University Hospital
    Systemic lupus erythematosus (SLE)
  • Monday, Nov 13th
    9:00 AM – 11:00 AM PT
    0907: Epstein Barr Virus Reactivation May Associate with Transition from Incomplete to Systemic Lupus Erythematosus
    Location: Poster Hall
    Abstract Poster Presenter: Benjamin Jones, BS (he/him/his) – Oklahoma State University
    Systemic lupus erythematosus (SLE)
  • Monday, Nov 13th
    9:00 AM – 11:00 AM PT
    0908: Association of Biologic Sex with Glycosphingolipids and the N-glycome in Lupus Nephritis and Renal Mesangial Cell Function
    Location: Poster Hall
    Abstract Poster Presenter: Tammy Nowling, PhD (she/her/hers) – Medical University of South Carolina
    Systemic lupus erythematosus (SLE)
  • Monday, Nov 13th
    9:00 AM – 11:00 AM PT
    0909: Rab4A Controls the Depletion of IL-2 in CD4+ T Cells via Enhanced CD38 Expression: Potential Involvement in Proinflammatory Lineage Development in Systemic Lupus Erythematosus
    Location: Poster Hall
    Abstract Poster Presenter: Joy Park, BA – Upstate Medical University
    Systemic lupus erythematosus (SLE)
  • Monday, Nov 13th
    9:00 AM – 11:00 AM PT
    0910: 17β-estradiol and B-cell Intrinsic Type I Interferon Amplify Toll-like Receptor 7 Signaling Loop in B Cells of Female Lupus Prone BXD2 Mice
    Location: Poster Hall
    Abstract Poster Presenter: Kathryn Sullivan, BS – University of Alabama-Birmingham
    Systemic lupus erythematosus (SLE)
  • Monday, Nov 13th
    9:00 AM – 11:00 AM PT
    0911: Spatial Transcriptomics Reveals Normal-density and Low-density Neutrophils Are More Prevalent Than Macrophages in Lupus Nephritis Glomeruli, and Urine DNA Methylation Analyses Capture Both Myeloid Populations
    Location: Poster Hall
    Abstract Poster Presenter: Joshua Skydel, MD (he/him/his) – Dartmouth-Hitchcock Medical Center
    Systemic lupus erythematosus (SLE)
  • Monday, Nov 13th
    9:00 AM – 11:00 AM PT
    0912: Inadequate Screening for Antiphospholipid Syndrome with Antiphospholipid Antibodies in Patients with Systemic Lupus Erythematosus
    Location: Poster Hall
    Abstract Poster Presenter: Mahnoor Sherazi, MBBS (she/her/hers) – State University of New York
    Systemic lupus erythematosus (SLE)
  • Monday, Nov 13th
    9:00 AM – 11:00 AM PT
    0913: Neutrophils in Patients with Systemic Lupus Erythematosus Show Pronounced Inflammatory Signals
    Location: Poster Hall
    Abstract Poster Presenter: Xiubo Fan, PhD (she/her/hers) – Singapore General Hospital
    Systemic lupus erythematosus (SLE)
  • Monday, Nov 13th
    9:00 AM – 11:00 AM PT
    0914: Transcription Factor RFX1 Promotes M1 Macrophage Polarization in Systemic Lupus Erythematosus via Regulating APOBEC3A
    Location: Poster Hall
    Abstract Poster Presenter: Ming Zhao, PhD – Institute of Dermatology, Chinese Academy of Medical Sciences and Peking Union Medical College
    Systemic lupus erythematosus (SLE)
  • Monday, Nov 13th
    9:00 AM – 11:00 AM PT
    0915: IL-16+ Is Abundantly Expressed by Kidney-infiltrating Myeloid and Lymphoid Cells in Lupus Nephritis: A Spatially Resolved Multiplexed Approach
    Location: Poster Hall
    Abstract Poster Presenter: Alessandra Ida Celia, MD (she/her/hers) – Sapienza University of Rome
    Systemic lupus erythematosus (SLE)
  • Monday, Nov 13th
    9:00 AM – 11:00 AM PT
    0916: Upregulation of the M-CSF Receptor on Non-Classical Monocytes from SLE Patients as an Indicator for Premature Monocyte Aging
    Location: Poster Hall
    Abstract Poster Presenter: Markus Zeisbrich, MD – University of Freiburg
    Systemic lupus erythematosus (SLE)
  • Monday, Nov 13th
    9:00 AM – 11:00 AM PT
    0917: Role of Immunoglobulin Polygenic Risk in Systemic Lupus Erythematosus
    Location: Poster Hall
    Abstract Poster Presenter: Victor Gothefors-Holm, MD, -None- – Uppsala University
    Systemic lupus erythematosus (SLE)
  • Monday, Nov 13th
    9:00 AM – 11:00 AM PT
    0918: Network Analysis of Genome Sequences Identifies Important Pathways in the Pathogenesis of Childhood-onset Systemic Lupus Erythematosus
    Location: Poster Hall
    Abstract Poster Presenter: Katharina Heitzman, BS – National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), National Institutes of Health (NIH)
    Systemic lupus erythematosus (SLE)
  • Monday, Nov 13th
    9:00 AM – 11:00 AM PT
    0919: Investigating the Role of Interferon in Promoting Flares of SLE at a Single Cell Level
    Location: Poster Hall
    Abstract Poster Presenter: Zoha Faheem, BSc (she/her/hers) – University of Toronto
    Systemic lupus erythematosus (SLE)
  • Monday, Nov 13th
    9:00 AM – 11:00 AM PT
    0920: Proinflammatory Neutrophils and NETs Mediate Skin and Kidney Inflammation During Lupus Flare in Asymptomatic Lupus-prone Mice Triggered by UVB
    Location: Poster Hall
    Abstract Poster Presenter: Ming-Lin Liu, PhD – University of Pennsylvania
    Systemic lupus erythematosus (SLE)
  • Monday, Nov 13th
    9:00 AM – 11:00 AM PT
    0921: SAPhigh T Peripheral Helper Cells Are a Novel Subset Associated with Lupus Nephritis
    Location: Poster Hall
    Abstract Poster Presenter: Yevgeniya Gartshteyn, MD, MS – Columbia University Medical Center
    Systemic lupus erythematosus (SLE)
  • Monday, Nov 13th
    9:00 AM – 11:00 AM PT
    0922: The Multi-Omic Landscape of Systemic Lupus Erythematosus Patients Highlights Metabolic and Immune Pathways Associated with Distinctive Clinical Profiles
    Location: Poster Hall
    Abstract Poster Presenter: Tomás Cerdó, PhD – IMIBIC/Reina Sofia Hospital/University of Cordoba
    Systemic lupus erythematosus (SLE)
  • Monday, Nov 13th
    9:00 AM – 11:00 AM PT
    0923: Identification of Lupus Nephritis Kidney Immune Populations via Hi-Resolution 20-Plex Immunohistochemistry Single-Cell Spatial Analyses
    Location: Poster Hall
    Abstract Poster Presenter: Caleb Marlin, PhD – Oklahoma Medical Research Foundation
    Systemic lupus erythematosus (SLE)
  • Monday, Nov 13th
    9:00 AM – 11:00 AM PT
    0924: Distinct Cell-Bound Complement Activation Products Associate with Disease Activity and Immune Transcriptional Signatures in SLE
    Location: Poster Hall
    Abstract Poster Presenter: Alfred Kim, MD, PhD (he/him/his) – Washington University School of Medicine
    Systemic lupus erythematosus (SLE)
  • Monday, Nov 13th
    9:00 AM – 11:00 AM PT
    0925: IL-4 Acts Through Aryl Hydrocarbon Receptor to Antagonize TLR7-induced Double Negative 2 B Cells in Lupus
    Location: Poster Hall
    Abstract Poster Presenter: John Mountz, MD, PhD – University Alabama Birmingham
    Systemic lupus erythematosus (SLE)
  • Monday, Nov 13th
    9:00 AM – 11:00 AM PT
    0926: Single-cell Multi-Omic Evaluation of Differences in Immune Cell Populations in Progression Toward Systemic Lupus Erythematosus
    Location: Poster Hall
    Abstract Poster Presenter: Aleksandra Bylinska – Oklahoma Medical Research Foundation
    Systemic lupus erythematosus (SLE)
  • Monday, Nov 13th
    9:00 AM – 11:00 AM PT
    0927: A Complex Interplay Among Gut Lachnoclostidium, HLA Haplotype DRB1*07:01, and the TNF Superfamily in Anti-Ro+ Women with a Spectrum of Preclinical and Clinical Autoimmunity Whose Children Have Neonatal Lupus
    Location: Poster Hall
    Abstract Poster Presenter: Robert Clancy, PhD – NYU Grossman School of Medicine
    Systemic lupus erythematosus (SLE)
  • Monday, Nov 13th
    9:00 AM – 11:00 AM PT
    0928: Skewing of B Cell Receptor Repertoire in Unswitched Memory B Cells Is Associated with Disease Activity of Systemic Lupus Erythematosus and Targeted by Belimumab
    Location: Poster Hall
    Abstract Poster Presenter: Keishi Fujio, MD, PhD – The University of Tokyo
    Systemic lupus erythematosus (SLE)
  • Monday, Nov 13th
    9:00 AM – 11:00 AM PT
    0929: Persistent Up- or Down-regulation of SOCS1 Exacerbates the Pathogenesis of Systemic Lupus Erythematosus Through Several Mechanisms
    Location: Poster Hall
    Abstract Poster Presenter: Reiko Takahashi, MD – Medical Research Institute KITANO HOSPITAL, PIIF Tazuke-Kofukai
    Systemic lupus erythematosus (SLE)
  • Monday, Nov 13th
    9:00 AM – 11:00 AM PT
    0930: Genetic Risk Profiles of Patients with Lupus Nephritis to Identify Those at Risk for Kidney Deterioration and Eventual Damage
    Location: Poster Hall
    Abstract Poster Presenter: Betty Tsao, PhD – Medical University of South Carolina
    Systemic lupus erythematosus (SLE)
  • Monday, Nov 13th
    9:00 AM – 11:00 AM PT
    0931: Down-Regulation of Human NADH-Ubiquinone Oxidoreductase Chain 6 by N6-Methyladenosine Methylation Is Associated with Lupus CD4+ T Cell Activation
    Location: Poster Hall
    Abstract Poster Presenter: Xuebing Feng, MD – Nanjing Drum Tower Hospital
    Systemic lupus erythematosus (SLE)
  • Monday, Nov 13th
    9:00 AM – 11:00 AM PT
    0932: The Landscape of Immune Cells in Systematic Lupus Erythematosus Patients with Epstein-Barr Virus Infection by Single-cell Sequencing
    Location: Poster Hall
    Abstract Poster Presenter: Lingzhen Hu, MMed – First Affiliated Hospital, Wenzhou medical University
    Systemic lupus erythematosus (SLE)
  • Monday, Nov 13th
    9:00 AM – 11:00 AM PT
    0933: WITHDRAWN
    Location: Poster Hall
    Systemic lupus erythematosus (SLE)
  • Monday, Nov 13th
    9:00 AM – 11:00 AM PT
    1442: Incident Vascular Events in Danish Nationwide Cohort of Patients with Newly Diagnosed Systemic Lupus Erythematosus
    Location: Poster Hall
    Abstract Poster Presenter: Renata Hansen, MD – Copenhagen Research Center for Autoimmune Connective Tissue Diseases, Copenhagen University Hospital, Rigshospitalet, Denmark
    Systemic lupus erythematosus (SLE)
  • Monday, Nov 13th
    9:00 AM – 11:00 AM PT
    1443: Vasculitis Associations Among Patients with Systemic Lupus Erythematous
    Location: Poster Hall
    Abstract Poster Presenter: Emily Cosentino, MD – Icahn School of Medicine at Mount Sinai Beth Israel
    Systemic lupus erythematosus (SLE)
  • Monday, Nov 13th
    9:00 AM – 11:00 AM PT
    1444: Identifying Determinants of Favourable and Poor Physical Function in Systemic Lupus Erythematosus: Results from an International Collaborative Study
    Location: Poster Hall
    Abstract Poster Presenter: Chris Wincup, MBBS, BSc, MRCP – King's College Hospital
    Systemic lupus erythematosus (SLE)
  • Monday, Nov 13th
    9:00 AM – 11:00 AM PT
    1445: SLESIS-R: An Improved Score for Prediction of Serious Infection in Patients with Systemic Lupus Erythematosus Based on the RELESSER Prospective Cohort
    Location: Poster Hall
    Abstract Poster Presenter: Iñigo Rua Figueroa, MD – Hospital de Gran Canaria Doctor Negrin
    Systemic lupus erythematosus (SLE)
  • Monday, Nov 13th
    9:00 AM – 11:00 AM PT
    1446: Glucocorticoids Use Is a Major Driver of Self-perceived Depression in Systemic Lupus Erythematosus: Insights from a Large, Prospective and Multicenter Study Using RELESSERPROS Register's Database
    Location: Poster Hall
    Abstract Poster Presenter: Iñigo Rua Figueroa, MD – Hospital de Gran Canaria Doctor Negrin
    Systemic lupus erythematosus (SLE)
  • Monday, Nov 13th
    9:00 AM – 11:00 AM PT
    1447: Increased Left Ventricular Mass Index in Systemic Lupus Erythematosus Patients with Lupus Nephritis Compared to Those Without Nephritis
    Location: Poster Hall
    Abstract Poster Presenter: Natalia Guajardo-Jauregui, MD (she/her/hers) – Hospital Universitario "Dr. Jose E. Gonzalez", Monterrey, Mexico
    Systemic lupus erythematosus (SLE)
  • Monday, Nov 13th
    9:00 AM – 11:00 AM PT
    1448: Association of Disease Activity and Anti-Double Stranded DNA Antibodies Titers with Echocardiographic Parameters in Systemic Lupus Erythematosus Patients
    Location: Poster Hall
    Abstract Poster Presenter: Natalia Guajardo-Jauregui, MD (she/her/hers) – Hospital Universitario "Dr. Jose E. Gonzalez", Monterrey, Mexico
    Systemic lupus erythematosus (SLE)
  • Monday, Nov 13th
    9:00 AM – 11:00 AM PT
    1449: Evaluation of Progression from Preclinical to Systemic Autoimmune Rheumatic Disease
    Location: Poster Hall
    Abstract Poster Presenter: Hana Salem Alahmari, Dr, MBBS, MSc, MRCP – King Khalid University
    Systemic lupus erythematosus (SLE)
  • Monday, Nov 13th
    9:00 AM – 11:00 AM PT
    1450: Clinical Manifestations and Outcomes in Systemic Lupus Erythematosus Patients Who Received Antiviral Therapy During the COVID-19 Omicron Variant Wave: Results from a Single Center Cohort of Puerto Rico
    Location: Poster Hall
    Abstract Poster Presenter: Lilliana Serrano Arroyo, MD, MPH (she/her/hers) – Centro Medico Episcopal San Lucas
    Systemic lupus erythematosus (SLE)
  • Monday, Nov 13th
    9:00 AM – 11:00 AM PT
    1451: Evaluation of Changes in SLE Patients’ Phenotype at Disease Onset, and Assessment of Disease Activity, Damage and Therapy at Diagnosis and During Follow up in the Last Forty Years: Preliminary Data of a Single Center Experience
    Location: Poster Hall
    Abstract Poster Presenter: Micaela Fredi, MD, PhD (she/her/hers) – UO Rheumatology and Clinical Immunology, Spedali Civili of Brescia
    Systemic lupus erythematosus (SLE)
  • Monday, Nov 13th
    9:00 AM – 11:00 AM PT
    1452: Inflammatory Markers and Left Ventricular Dysfunction in Systemic Lupus Erythematosus (SLE)
    Location: Poster Hall
    Abstract Poster Presenter: Audrey Hagiwara, MD (she/her/hers) – Cedars-Sinai Medical Center
    Systemic lupus erythematosus (SLE)
  • Monday, Nov 13th
    9:00 AM – 11:00 AM PT
    1453: Musculoskeletal Involvement in Systemic Lupus Erythematosus: Insights from a Survey of Lupus Experts
    Location: Poster Hall
    Abstract Poster Presenter: Rashmi Dhital, MD – UC San Diego
    Systemic lupus erythematosus (SLE)
  • Monday, Nov 13th
    9:00 AM – 11:00 AM PT
    1454: Neuropsychiatric Systemic Lupus Erythematosus in Children: A Scoping Review
    Location: Poster Hall
    Abstract Poster Presenter: Alexandra Theisen, MD, MS – Saint Louis University, SSM Health Cardinal Glennon Children's Hospital
    Systemic lupus erythematosus (SLE)
  • Monday, Nov 13th
    9:00 AM – 11:00 AM PT
    1455: Risk Factors of Cytomegalovirus Reactivation and Disease in Patients with Systemic Lupus Erythematosus
    Location: Poster Hall
    Abstract Poster Presenter: Miyu Wakatsuki, MD – National Center for Global Health and Medicine
    Systemic lupus erythematosus (SLE)
  • Monday, Nov 13th
    9:00 AM – 11:00 AM PT
    1456: Systematic Review of Effects of Systemic Lupus Erythematosus on Brain Structure and Structural Connectivity and Its Relationship with Cognitive Dysfunction Through an Advanced Neuroimaging Lens
    Location: Poster Hall
    Abstract Poster Presenter: Santiago Arciniegas, MSc – The Hospital for Sick Children
    Systemic lupus erythematosus (SLE)
  • Monday, Nov 13th
    9:00 AM – 11:00 AM PT
    1457: Obesity Is an Independent Poor Prognostic Factor in Lupus Nephritis
    Location: Poster Hall
    Abstract Poster Presenter: Francy Cuervo, MD, MSc (she/her/hers) – Colsubsidio
    Systemic lupus erythematosus (SLE)
  • Monday, Nov 13th
    9:00 AM – 11:00 AM PT
    1458: Activated Naïve DNA-Reactive B Cells in Lupus Nephritis Patients Are Increased and Associated with Disease Activity
    Location: Poster Hall
    Abstract Poster Presenter: Francesca Faustini, MD, PhD – Karolinska Institutet, Karolinska Unversity Hospital, Stockholm, Sweden
    Systemic lupus erythematosus (SLE)
  • Monday, Nov 13th
    9:00 AM – 11:00 AM PT
    1459: Unveiling the Impact of Neuropsychiatric Involvement in Systemic Lupus Erythematosus on Damage Accrual
    Location: Poster Hall
    Abstract Poster Presenter: Dionysis Nikolopoulos, MD – Karolinska Institutet and Karolinska University Hospital, Division of Rheumatology, Department of Medicine Solna
    Systemic lupus erythematosus (SLE)
  • Monday, Nov 13th
    9:00 AM – 11:00 AM PT
    1460: Impact of Neuropsychiatric Involvement on Health-related Quality of Life in Patients with Systemic Lupus Erythematosus
    Location: Poster Hall
    Abstract Poster Presenter: Dionysis Nikolopoulos, MD – Karolinska Institutet and Karolinska University Hospital, Division of Rheumatology, Department of Medicine Solna
    Systemic lupus erythematosus (SLE)
  • Monday, Nov 13th
    9:00 AM – 11:00 AM PT
    1461: Association of Serum Analytes with SLE Cognitive Impairment Phenotypes Formed by Machine Learning: MMP-9, S100A8/A9, IL-6, IL-10, and NGAL
    Location: Poster Hall
    Abstract Poster Presenter: Carolina Munoz-Grajales, MD, PhD (she/her/hers) – UHN/TWH
    Systemic lupus erythematosus (SLE)
  • Monday, Nov 13th
    9:00 AM – 11:00 AM PT
    1462: Cardiovascular Damage in Systemic Lupus Erythematosus Occurs at Early Stages of the Disease. Chronological Analysis of Damage Accrual in a Large Cohort from the Spanish Society of Rheumatology Lupus Registry (RELESSER)
    Location: Poster Hall
    Abstract Poster Presenter: Sara Garcia Perez, MD – Complejo Hospitalario Universitario de Vigo
    Systemic lupus erythematosus (SLE)
  • Monday, Nov 13th
    9:00 AM – 11:00 AM PT
    1463: Predictors of Cognitive Impairment in Individuals with Systemic Lupus Erythematosus
    Location: Poster Hall
    Abstract Poster Presenter: Alexandra Lee, MD – Meharry Medical College
    Systemic lupus erythematosus (SLE)
  • Monday, Nov 13th
    9:00 AM – 11:00 AM PT
    1464: Lupus Flares More Common in Patients on Dialysis Compared to After Renal Transplant: A Systematic Review and Meta-analysis
    Location: Poster Hall
    Abstract Poster Presenter: Omer Pamuk, MD – University Hospitals Cleveland Medical Center
    Systemic lupus erythematosus (SLE)
  • Monday, Nov 13th
    9:00 AM – 11:00 AM PT
    1465: Blood-dominant Disease in Older-onset Lupus: A Systematic Review and Meta-analysis
    Location: Poster Hall
    Abstract Poster Presenter: Sarah Abi Doumeth, MD – Case Western Reserve University/University Hospitals Cleveland Medical Center
    Systemic lupus erythematosus (SLE)
  • Monday, Nov 13th
    9:00 AM – 11:00 AM PT
    1466: Impact of Co-morbid Depression on Systemic Lupus Erythematosus Hospitalizations: Insights from National Readmission Database 2020
    Location: Poster Hall
    Abstract Poster Presenter: Shreena Kamlesh Gandhi, MD, MBBS – Kansas University School of Medicine - Wichita
    Systemic lupus erythematosus (SLE)
  • Monday, Nov 13th
    9:00 AM – 11:00 AM PT
    1467: Antiphospholipid Antibodies and the Risk of Diffuse Alveolar Hemorrhage in Patients with Systemic Lupus Erythematosus: A Systematic Review and Meta-Analysis
    Location: Poster Hall
    Abstract Poster Presenter: Mariana Gonzalez-Trevino, MD – Mayo Clinic
    Systemic lupus erythematosus (SLE)
  • Monday, Nov 13th
    9:00 AM – 11:00 AM PT
    1468: Prediction of Cardiovascular Disease in Patients with Systemic Lupus Erythematosus Using a Machine Learning Algorithm for Time-to-Event Outcomes: Random Survival Forest
    Location: Poster Hall
    Abstract Poster Presenter: Hsin Yen Liu, MD – University of Toronto
    Systemic lupus erythematosus (SLE)
  • Monday, Nov 13th
    9:00 AM – 11:00 AM PT
    1469: Prevalence of Cardiovascular Disease in a Populations Based Registry of Patients with Systemic Lupus Erythematosus
    Location: Poster Hall
    Abstract Poster Presenter: Daniel Joyce, BS – NYU Grossman School of Medicine
    Systemic lupus erythematosus (SLE)
  • Monday, Nov 13th
    9:00 AM – 11:00 AM PT
    1470: SARS-CoV-2 Antibody Formation After COVID-19 Vaccination in SLE Patients Treated with Belimumab: Single-Center Prospective Observational Study
    Location: Poster Hall
    Abstract Poster Presenter: Eunsong Kang, MD – Korea University Ansan Hospital
    Systemic lupus erythematosus (SLE)
  • Monday, Nov 13th
    9:00 AM – 11:00 AM PT
    1471: A Comparative Study of Lupus Nephritis Class II and IgA Nephropathy: Renal Disease Other Than Lupus Nephritis in Systemic Lupus Erythematosus Patients
    Location: Poster Hall
    Abstract Poster Presenter: Eunsong Kang, MD – Korea University Ansan Hospital
    Systemic lupus erythematosus (SLE)
  • Monday, Nov 13th
    9:00 AM – 11:00 AM PT
    1472: Prevalence of Hepatic Injury in Patients with Systemic Lupus Erythematosus: A 28-Year Single Center Experience
    Location: Poster Hall
    Abstract Poster Presenter: Sarfaraz Hasni, MD, MSc – National Institutes of Health
    Systemic lupus erythematosus (SLE)
  • Monday, Nov 13th
    9:00 AM – 11:00 AM PT
    1473: Mortality from Diseases of the Nervous System in Patients with Lupus in the past Two Decades
    Location: Poster Hall
    Abstract Poster Presenter: Ansaam Daoud, MD – Case Western Reserve University/University Hospitals
    Systemic lupus erythematosus (SLE)
  • Monday, Nov 13th
    9:00 AM – 11:00 AM PT
    1474: Associations and Outcomes of Critical Peripheral Ischemia in Systemic Lupus Erythematosus (SLE): Data from Indian SLE Inception Cohort for Research (INSPIRE)
    Location: Poster Hall
    Abstract Poster Presenter: Liza Rajasekhar, MD, MBBS – Nizam's Institute of Medical Sciences
    Systemic lupus erythematosus (SLE)
  • Monday, Nov 13th
    9:00 AM – 11:00 AM PT
    1475: Retrospective Study of Obesity on Clinical and Immunological Features in Systemic Lupus Erythematosus Using AI Software Deep 6 and EPIC Slicer Dicer
    Location: Poster Hall
    Abstract Poster Presenter: Shivani Shah, DO (she/her/hers) – Ochsner Clinic Foundation
    Systemic lupus erythematosus (SLE)
  • Monday, Nov 13th
    9:00 AM – 11:00 AM PT
    1476: Discriminating Disease Flare from Infection in Febrile Patients with Systemic Lupus Erythematosus Admitted to a Safety-Net Hospital System: A Retrospective, Multicenter Study
    Location: Poster Hall
    Abstract Poster Presenter: Abhimanyu Amarnani, MD, PhD – NYU Langone Medical Center
    Systemic lupus erythematosus (SLE)
  • Monday, Nov 13th
    9:00 AM – 11:00 AM PT
    1477: Clinical and Economic Burden of Herpes Zoster in Patients with Systemic Lupus Erythematosus: A Retrospective Cohort Study
    Location: Poster Hall
    Abstract Poster Presenter: Nikita Stempniewicz, MSc – GSK
    Systemic lupus erythematosus (SLE)
  • Monday, Nov 13th
    9:00 AM – 11:00 AM PT
    1478: Presentation and Outcomes of Posterior Reversible Encephalopathy Syndrome in Systemic Lupus Erythematosus: A Multicenter Cohort and a Systematic Literature Review
    Location: Poster Hall
    Abstract Poster Presenter: Alain Sanchez-Rodriguez, MD – Mayo Clinic
    Systemic lupus erythematosus (SLE)
  • Monday, Nov 13th
    9:00 AM – 11:00 AM PT
    1479: Risk Factors for Human Papillomavirus Cervical Infection and Clearance in Patients with Systemic Lupus Erythematosus: The PAPILUP Study
    Location: Poster Hall
    Abstract Poster Presenter: Arthur Mageau, MD, MSc – Université Paris Cité
    Systemic lupus erythematosus (SLE)
  • Monday, Nov 13th
    9:00 AM – 11:00 AM PT
    1480: Demographic and Clinical Characteristics of Patients with LN: A Multicenter Study from the Gulf Region
    Location: Poster Hall
    Abstract Poster Presenter: Jamal Al-Saleh, MD – Dubai Health Authority
    Systemic lupus erythematosus (SLE)
  • Monday, Nov 13th
    9:00 AM – 11:00 AM PT
    1481: Racial Disparities in Lupus Nephritis: A Nationwide Analysis
    Location: Poster Hall
    Abstract Poster Presenter: Faria Sami, MD – John H. Stroger Hospital of Cook County
    Systemic lupus erythematosus (SLE)
  • Monday, Nov 13th
    9:00 AM – 11:00 AM PT
    1482: Change in the SLE Mortality Rate and Prevalence of Lupus Nephritis Overtime: Single Center Retrospective Study in Japan
    Location: Poster Hall
    Abstract Poster Presenter: Takehiro Nakai, MD – St. Luke's International Hospital
    Systemic lupus erythematosus (SLE)
  • Monday, Nov 13th
    9:00 AM – 11:00 AM PT
    1483: High Chronicity Index of the Modified NIH (National Institute of Health) Scoring System of Lupus Nephritis Is Associated with Increased Risk of End-stage Kidney Disease: A Retrospective Single-center Study
    Location: Poster Hall
    Abstract Poster Presenter: Shiori Nakagawa, MD, PhD – Toshifumi Gabata
    Systemic lupus erythematosus (SLE)
  • Monday, Nov 13th
    9:00 AM – 11:00 AM PT
    1484: Ruminococcus Implicated in the Clinical Development of Lupus Nephritis: A Systematic Review of the Literature
    Location: Poster Hall
    Abstract Poster Presenter: Katarzyna Karpinska-Leydier, MD – Florida State University
    Systemic lupus erythematosus (SLE)
  • Monday, Nov 13th
    9:00 AM – 11:00 AM PT
    1485: Risk of Diabetes Mellitus in Systemic Lupus Erythematosus: Systematic Review and Meta-analysis
    Location: Poster Hall
    Abstract Poster Presenter: Claudia Mendoza-Pinto, MD, PhD (she/her/hers) – Instituto Mexicano del Seguro Social
    Systemic lupus erythematosus (SLE)
  • Monday, Nov 13th
    9:00 AM – 11:00 AM PT
    1486: Clinical Outcomes in Patients Admitted for ST-Elevation Myocardial Infarction with vs Without Systemic Lupus Erythematosus: An Analysis from National Inpatient Sample Database (2015-2018)
    Location: Poster Hall
    Abstract Poster Presenter: Mashal Awais, MD – Southeast Health
    Systemic lupus erythematosus (SLE)
  • Monday, Nov 13th
    9:00 AM – 11:00 AM PT
    1487: Prevalence of Objectively Measured Sleep Disturbance in Systemic Lupus Erythematosus (SLE)
    Location: Poster Hall
    Abstract Poster Presenter: Patti Katz, PhD (she/her/hers) – UCSF
    Systemic lupus erythematosus (SLE)
  • Monday, Nov 13th
    9:00 AM – 11:00 AM PT
    1488: Association of Glucocorticoid Use with Patient-Reported Outcomes Among Persons with Systemic Lupus Erythematosus
    Location: Poster Hall
    Abstract Poster Presenter: Patti Katz, PhD (she/her/hers) – UCSF
    Systemic lupus erythematosus (SLE)
  • Monday, Nov 13th
    9:00 AM – 11:00 AM PT
    1489: Treatment with Upadacitinib in Patients with Systemic Lupus Erythematosus Results in the Inhibition of B-Cell–related Biomarkers: Analysis of the M19-130 (SLEek) Phase 2 Study
    Location: Poster Hall
    Abstract Poster Presenter: Marie-Claude Gaudreau, PhD – Abbvie
    Systemic lupus erythematosus (SLE)
  • Monday, Nov 13th
    9:00 AM – 11:00 AM PT
    1490: Early Experience with SGLT2i in Systemic Lupus Erythematosus
    Location: Poster Hall
    Abstract Poster Presenter: Michelle Petri, MD, MPH (she/her/hers) – Johns Hopkins University School of Medicine
    Systemic lupus erythematosus (SLE)
  • Monday, Nov 13th
    9:00 AM – 11:00 AM PT
    1491: Targeting the Mevalonate Pathway-dependent Protein Geranylgeranylation to Restrict Follicular Helper T Cell Differentiation for the Treatment of Systemic Lupus Erythematosus
    Location: Poster Hall
    Abstract Poster Presenter: Lai Wang – Institute of Dermatology, Chinese Academy of Medical Sciences and Peking Union Medical College
    Systemic lupus erythematosus (SLE)
  • Monday, Nov 13th
    9:00 AM – 11:00 AM PT
    1492: Pre-treatment Differentially Expressed Metagenes Characterize Systemic Lupus Patients Who Subsequently Achieve Clinical Response to Belimumab
    Location: Poster Hall
    Abstract Poster Presenter: Miles Smith, PhD (he/him/his) – Oklahoma Medical Research Foundation
    Systemic lupus erythematosus (SLE)
  • Monday, Nov 13th
    9:00 AM – 11:00 AM PT
    1493: Novel BCMA-CD19 Compound CAR-T (cCAR) Targets B Cells and Plasma Cells Achieving Immune Reset and Eliminates All Autoantibodies in Systemic Lupus Erythematosus (SLE) and Lupus Nephritis (LN) Patients Resulting in Long-Term, Medication-Free Remission
    Location: Poster Hall
    Abstract Poster Presenter: Greg Deener, BS – iCell Gene Therapeutics Inc.
    Systemic lupus erythematosus (SLE)
  • Monday, Nov 13th
    9:00 AM – 11:00 AM PT
    1494: The Effect of Belimumab on Steroid Use in Patients with SLE: Results from a Retrospective Observational Study of Real-World Data from a US Rheumatology Provider Network
    Location: Poster Hall
    Abstract Poster Presenter: Karen Worley, PhD, MS – GlaxoSmithKline, US Value, Evidence and Outcomes
    Systemic lupus erythematosus (SLE)
  • Monday, Nov 13th
    9:00 AM – 11:00 AM PT
    1495: Deep Serological Profiling of SLE Patients Treated with anti-CD19 CAR T Cells
    Location: Poster Hall
    Abstract Poster Presenter: Samik Basu, MD (he/him/his) – Cabaletta Bio
    Systemic lupus erythematosus (SLE)
  • Monday, Nov 13th
    9:00 AM – 11:00 AM PT
    1496: Clinical Safety and Efficacy Results from EQUALISE Type B: A Phase 1b Open-label Clinical Study of Itolizumab, a Novel anti-CD6 Therapy, in Subjects with Active Proliferative Lupus Nephritis
    Location: Poster Hall
    Abstract Poster Presenter: Kenneth Kalunian, MD, FACR – UC San Diego
    Systemic lupus erythematosus (SLE)
  • Monday, Nov 13th
    9:00 AM – 11:00 AM PT
    1497: Eltrombopag in SLE-Associated Thrombocytopenia: Treatment Response and Thrombotic Complications
    Location: Poster Hall
    Abstract Poster Presenter: Nouran Eshak, MBChB – Mayo Clinic Arizona
    Systemic lupus erythematosus (SLE)
  • Monday, Nov 13th
    9:00 AM – 11:00 AM PT
    1498: First-in-Human Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics Study of DS-7011a, an Anti-TLR7 Antagonistic Monoclonal Antibody for the Treatment of Systemic Lupus Erythematosus
    Location: Poster Hall
    Abstract Poster Presenter: Giorgio Senaldi, MD, PhD – Daiichi Sankyo
    Systemic lupus erythematosus (SLE)
  • Monday, Nov 13th
    9:00 AM – 11:00 AM PT
    1499: Year-5 Follow-up of Belimumab Safety (mortality and Malignancies) in Patients with Systemic Lupus Erythematosus (SLE) Who Completed a Phase 4, 52-week, Randomized, Double-blind Placebo-controlled Safety Study
    Location: Poster Hall
    Abstract Poster Presenter: Saira Sheikh, MD – University of North Carolina at Chapel Hill
    Systemic lupus erythematosus (SLE)
  • Monday, Nov 13th
    9:00 AM – 11:00 AM PT
    1500: Cumulative Infections by Week 52 Among Patients with SLE: A Summary of Data from Placebo-Controlled Belimumab Studies
    Location: Poster Hall
    Abstract Poster Presenter: Saira Sheikh, MD – University of North Carolina at Chapel Hill
    Systemic lupus erythematosus (SLE)
  • Monday, Nov 13th
    9:00 AM – 11:00 AM PT
    1501: Lupus Low Disease Activity State (LLDAS) Achievement with Deucravacitinib, an Oral, Selective, Allosteric Tyrosine Kinase 2 Inhibitor, in a Phase 2 Trial in SLE
    Location: Poster Hall
    Abstract Poster Presenter: Eric Morand, MD, PhD – Monash University
    Systemic lupus erythematosus (SLE)
  • Monday, Nov 13th
    9:00 AM – 11:00 AM PT
    1502: Introduction of Belimumab Within Five Years of the Onset of Systemic Lupus Erythematosus (SLE) Contributes to the Better Therapeutic Response; A Multi-center Retrospective Cohort Study
    Location: Poster Hall
    Abstract Poster Presenter: Kanako Kojima, MD – Nagasaki university graduate school
    Systemic lupus erythematosus (SLE)
  • Monday, Nov 13th
    9:00 AM – 11:00 AM PT
    1503: Disease Course and Complement as Predictors of Response to Standard of Care Plus Placebo in Patients with SLE: A Post Hoc Analysis of Dapirolizumab Pegol and Epratuzumab Clinical Trial Data
    Location: Poster Hall
    Abstract Poster Presenter: Joan Merrill, MD – Oklahoma Medical Research Foundation
    Systemic lupus erythematosus (SLE)
  • Monday, Nov 13th
    9:00 AM – 11:00 AM PT
    1504: Characteristics and Prior Treatment Journey of Systemic Lupus Erythematosus (SLE) Patients Who Were Prescribed Anifrolumab -- Observations from the American Rheumatology Network (ARN) in the U.S
    Location: Poster Hall
    Abstract Poster Presenter: Vasileios Kyttaris, MD, PhD – BIDMC
    Systemic lupus erythematosus (SLE)
  • Monday, Nov 13th
    9:00 AM – 11:00 AM PT
    1505: Long-term Safety and Efficacy of Voclosporin in Black Patients with Lupus Nephritis: Results from the AURORA 1 and AURORA 2 Studies
    Location: Poster Hall
    Abstract Poster Presenter: Henry Leher, PhD – Aurinia Pharma
    Systemic lupus erythematosus (SLE)
  • Monday, Nov 13th
    9:00 AM – 11:00 AM PT
    1506: Prescribing Patterns in Lupus Nephritis: Analyzing Time from Proteinuria to Prescription of ACE/ARB
    Location: Poster Hall
    Abstract Poster Presenter: Jacqueline Jansz, MD (she/her/hers) – University of Illinois at Chicago Hospital
    Systemic lupus erythematosus (SLE)
  • Monday, Nov 13th
    9:00 AM – 11:00 AM PT
    1507: Pharmacodynamic Changes in SLE Relevant Gene Expression Induced by Deucravacitinib in Patients Enrolled in the Phase 2 PAISLEY Trial
    Location: Poster Hall
    Abstract Poster Presenter: Yanhua Sarah Hu, PhD – Bristol-Myers Squibb
    Systemic lupus erythematosus (SLE)
  • Monday, Nov 13th
    9:00 AM – 11:00 AM PT
    1508: Predicting in Virtual Patients the Efficacy of an Anti IFNa Mab in Cutaneous Lupus Erythematosus
    Location: Poster Hall
    Abstract Poster Presenter: Philippe MOINGEON, PhD (he/him/his) – Servier Laboratories, France
    Systemic lupus erythematosus (SLE)
  • Monday, Nov 13th
    9:00 AM – 11:00 AM PT
    1509: Calcineurin Inhibitors for Treatment of Lupus Nephritis: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
    Location: Poster Hall
    Abstract Poster Presenter: Gabriel Figueroa-Parra, MD – Mayo Clinic
    Systemic lupus erythematosus (SLE)
  • Monday, Nov 13th
    9:00 AM – 11:00 AM PT
    1510: Efficacy of Gonadotropin-releasing Hormone Agonist (GnRHa) in Ovarian Preservation in Women with Systemic Lupus Erythematosus (SLE) Receiving Cyclophosphamide (CYC)
    Location: Poster Hall
    Abstract Poster Presenter: Jun Chu, APRN, CRNP – National Institutes of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), National Institutes of Health (NIH)
    Systemic lupus erythematosus (SLE)
  • Monday, Nov 13th
    9:00 AM – 11:00 AM PT
    1511: B-Cell Recovery in a Randomized Controlled Trial of B-Cell Depletion with Obinutuzumab for the Treatment of Proliferative Lupus Nephritis
    Location: Poster Hall
    Abstract Poster Presenter: Ed Vital, MD – University of Leeds
    Systemic lupus erythematosus (SLE)
  • Monday, Nov 13th
    9:00 AM – 11:00 AM PT
    1512: Rituximab Objective Outcome Measures Trial in SLE (ROOTS): Randomised and Rescue Therapy Outcomes from a Randomised Controlled Trial
    Location: Poster Hall
    Abstract Poster Presenter: Ed Vital, MD – University of Leeds
    Systemic lupus erythematosus (SLE)
  • Monday, Nov 13th
    11:00 AM – 11:10 AM PT
    1579: Sodium-Glucose Co-transporter-2 Inhibitors and the Risk of Cardiac and Renal Outcomes in Systemic Lupus Erythematosus
    Location: Exhibit Hall A-B
    Plenary Presenter: April Jorge, MD – Massachusetts General Hospital
    Systemic lupus erythematosus (SLE)
  • Monday, Nov 13th
    2:00 PM – 3:30 PM PT
    13M150: Abstracts: SLE – Etiology & Pathogenesis (1597–1602)
    Location: Room 6F/6C
    Abstract Moderator: Melissa Cunningham, MD, PhD – Medical University of SC
    Abstract Moderator: Betty Tsao, PhD – Medical University of South Carolina
    Systemic lupus erythematosus (SLE)
  • Monday, Nov 13th
    2:00 PM – 2:10 PM PT
    1597: Staphylococcus Aureus Peptidoglycan Induces Pathogenic Autoantibody Production via Autoreactive B Cell Receptor Clonal Selection, Implications in Systemic Lupus Erythematosus
    Location: Room 6F/6C
    Presenting Author: Wei Jiang, PhD – Medical University of South Carolina
    Systemic lupus erythematosus (SLE)
  • Monday, Nov 13th
    2:15 PM – 2:25 PM PT
    1598: Single-cell Spatial Proteomics Identifies Intraglomerular Myeloid Cells in Membranous Lupus Nephritis
    Location: Room 6F/6C
    Presenting Author: Andrea Fava, MD – Johns Hopkins University
    Systemic lupus erythematosus (SLE)
  • Monday, Nov 13th
    2:30 PM – 2:40 PM PT
    1599: Single-Cell RNA Sequencing Reveals Cellular Drivers of UV-mediated Skin Injury in Cutaneous Lupus
    Location: Room 6F/6C
    Presenting Author: Mitra Maz, BA (she/her/hers) – University of Michigan Medical School
    Systemic lupus erythematosus (SLE)
  • Monday, Nov 13th
    2:45 PM – 2:55 PM PT
    1600: Transcriptomic Characterization of Class II Lupus Nephritis and Outcomes
    Location: Room 6F/6C
    Presenting Author: Jasmine Shwetar – New York School of Medicine
    Systemic lupus erythematosus (SLE)
  • Monday, Nov 13th
    3:00 PM – 3:10 PM PT
    1601: Interleukin-6 Disrupts Blood-cerebrospinal Fluid Barrier Permeability in Murine Neuropsychiatric Lupus
    Location: Room 6F/6C
    Presenting Author: Chaim Putterman, MD – Albert Einstein College of Medicine
    Systemic lupus erythematosus (SLE)
  • Monday, Nov 13th
    3:15 PM – 3:25 PM PT
    1602: NADPH Oxidase Exerts a B Cell-intrinsic Contribution to Lupus Risk by Modulating Endosomal Toll-like Receptor (TLR) Signals
    Location: Room 6F/6C
    Presenting Author: Shaun Jackson, MD, PhD – Seattle Children's Research Institute
    Systemic lupus erythematosus (SLE)
  • Monday, Nov 13th
    4:00 PM – 5:30 PM PT
    13M166: Abstracts: SLE – Diagnosis, Manifestations, & Outcomes II: Omics (1693–1698)
    Location: Room 6F/6C
    Abstract Moderator: Deepak Rao, MD, PhD – Brigham and Women's Hospital
    Abstract Moderator: Rae Yeung, MD, PhD – The Hospital for Sick Children, University of Toronto
    Systemic lupus erythematosus (SLE)
  • Monday, Nov 13th
    4:00 PM – 4:10 PM PT
    1693: Blood Immunophenotyping Distinguishes Three Subgroups of Lupus Nephritis Patients with Distinct Kidney Infiltrates and Interferon Signatures
    Location: Room 6F/6C
    Presenting Author: Alice Horisberger, MD – Brigham and Woman's Hospital, Harvard medical school
    Systemic lupus erythematosus (SLE)
  • Monday, Nov 13th
    4:15 PM – 4:25 PM PT
    1694: Transcriptomic Analysis of the Impact of Iberdomide on Patients with SLE
    Location: Room 6F/6C
    Presenting Author: Peter Lipsky, MD – AMPEL BioSolutions
    Systemic lupus erythematosus (SLE)
  • Monday, Nov 13th
    4:30 PM – 4:40 PM PT
    1695: Single Cell Transcriptomics in Kidney Tissue from African American Patients Enrolled in the Accelerating Medicines Partnership (AMP) Implicates Tubular Cells in the Pathogenesis of APOL1 Associated Lupus Nephritis
    Location: Room 6F/6C
    Presenting Author: Philip Carlucci, MD – New York University School of Medicine
    Systemic lupus erythematosus (SLE)
  • Monday, Nov 13th
    4:45 PM – 4:55 PM PT
    1696: Multi-Omic Profiling Reveals Immune Cell Priming Signature Linked to Systemic Lupus Erythematosus Prognosis
    Location: Room 6F/6C
    Presenting Author: Sarfaraz Hasni, MD, MSc – National Institutes of Health
    Systemic lupus erythematosus (SLE)
  • Monday, Nov 13th
    5:00 PM – 5:10 PM PT
    1697: Molecular Characterisation of Remission and Lupus Low Disease Activity State (LLDAS) by Whole-Blood Transcriptome-Based Pathways in a Pan-European Systemic Lupus Erythematosus Cohort
    Location: Room 6F/6C
    Presenting Author: Ioannis Parodis, MD, PhD – Karolinska Institutet
    Systemic lupus erythematosus (SLE)
  • Monday, Nov 13th
    5:15 PM – 5:25 PM PT
    1698: High-throughput Proteomics Identities a Spectrum of Novel Serum Biomarkers of Lupus Nephritis
    Location: Room 6F/6C
    Presenting Author: Huihua Ding, MD – Shanghai Jiao Tong University School of Medicine
    Systemic lupus erythematosus (SLE)
  • Tuesday, Nov 14th
    9:00 AM – 10:00 AM PT
    14T117: Lupus in Africa
    Location: Room 11A-B
    Moderator: Angela Migowa, MBChB, MMed – AGA KHAN UNIVERSITY
    Moderator: Noelle A. Rolle, MBBS – Medical College of Georgia at Augusta University
    Systemic lupus erythematosus (SLE)
     CME: 1 hours
  • Tuesday, Nov 14th
    9:00 AM – 9:15 AM PT
    Immunologic and Genetic Phenotypes of Systemic Lupus Erythematosus in Africa
    Location: Room 11A-B
    Speaker: Kate Webb, MD, PhD (she/her/hers) – Red Cross Children's Hospital, Cape Town
    Systemic lupus erythematosus (SLE)
  • Tuesday, Nov 14th
    9:15 AM – 9:30 AM PT
    Clinical Presentation of SLE in Africa
    Location: Room 11A-B
    Speaker: Ida Dey, MD, MSc, FRCP, MACR – University of Ghana Medical School
    Systemic lupus erythematosus (SLE)
  • Tuesday, Nov 14th
    9:30 AM – 9:45 AM PT
    Research Developments and Future Directions
    Location: Room 11A-B
    Speaker: Hakeem Olaosebikan, MBBS – Lagos State University
    Systemic lupus erythematosus (SLE)
  • Tuesday, Nov 14th
    9:45 AM – 10:00 AM PT
    Q&A
    Location: Room 11A-B
    Systemic lupus erythematosus (SLE)
  • Tuesday, Nov 14th
    9:00 AM – 11:00 AM PT
    (2257–2325) SLE – Diagnosis, Manifestations, & Outcomes Poster III
    Location: Poster Hall
    Systemic lupus erythematosus (SLE)
  • Tuesday, Nov 14th
    9:00 AM – 11:00 AM PT
    (2326–2351) SLE – Treatment Poster III
    Location: Poster Hall
    Systemic lupus erythematosus (SLE)
  • Tuesday, Nov 14th
    9:00 AM – 11:00 AM PT
    L02: Mutational Analysis of UNC93B1 Identifies Regulatory Regions Mutated in Human SLE
    Location: Poster Hall
    Late-Breaking Poster Presenter: John P. Huizar, MD (he/him/his) – UCSF
    Systemic lupus erythematosus (SLE)
  • Tuesday, Nov 14th
    9:00 AM – 11:00 AM PT
    L13: An Open-label, Multicenter, Phase 1/2 Study to Assess Safety, Efficacy and Cellular Kinetics of YTB323, a Rapid Manufacturing CAR-T Cell Therapy Targeting CD19 on B Cells, for Severe Refractory Systemic Lupus Erythematosus: Preliminary Results
    Location: Poster Hall
    Late-Breaking Poster Presenter: Giulio Cavalli, MD, PhD – Novartis
    Systemic lupus erythematosus (SLE)
  • Tuesday, Nov 14th
    9:00 AM – 11:00 AM PT
    2257: Outcomes and Clinical Features of Acute Coronary Syndrome in Patients with SLE: A 14-Year Real-World Study (2006-2019)
    Location: Poster Hall
    Abstract Poster Presenter: Konstantinos Parperis, MD, FACP, FACR – University of Cyprus Medical School
    Systemic lupus erythematosus (SLE)
  • Tuesday, Nov 14th
    9:00 AM – 11:00 AM PT
    2258: Brain Activity Patterns and Behavioural Performance in SLE Patients During a Spatial Working Memory and Sustained Attention Task
    Location: Poster Hall
    Abstract Poster Presenter: Zahi Touma, MD, PhD – University of Toronto
    Systemic lupus erythematosus (SLE)
  • Tuesday, Nov 14th
    9:00 AM – 11:00 AM PT
    2260: Right Insular Cortex-Thalamic Functional Connectivity as a Potential Marker for Fatigue in Systemic Lupus Erythematosus and Primary Sjögren's Syndrome
    Location: Poster Hall
    Abstract Poster Presenter: Yuichiro Fujieda, MD, PhD – Hokkaido University Hospital
    Systemic lupus erythematosus (SLE)
  • Tuesday, Nov 14th
    9:00 AM – 11:00 AM PT
    2261: Burden of Flare and Organ Damage in Systemic Lupus Erythematosus (SLE) in the Asia Pacific Region: A Multicenter Cohort Study
    Location: Poster Hall
    Abstract Poster Presenter: Eric Morand, MD, PhD – Monash University
    Systemic lupus erythematosus (SLE)
  • Tuesday, Nov 14th
    9:00 AM – 11:00 AM PT
    2262: Identifying Important Domains for Inclusion in a Novel Treatment Response Measure for Systemic Lupus Erythematosus (TRM-SLE): Results of a Modified Delphi Study
    Location: Poster Hall
    Abstract Poster Presenter: Eric Morand, MD, PhD – Monash University
    Systemic lupus erythematosus (SLE)
  • Tuesday, Nov 14th
    9:00 AM – 11:00 AM PT
    2263: Disease Activity Progression in Systemic Lupus Erythematosus: An Analysis of the SLE Prospective Observational Cohort Study (SPOCS)
    Location: Poster Hall
    Abstract Poster Presenter: Eric Morand, MD, PhD – Monash University
    Systemic lupus erythematosus (SLE)
  • Tuesday, Nov 14th
    9:00 AM – 11:00 AM PT
    2264: Proposal for Defining Moderate and Severe Activity States in Systemic Lupus Erythematosus. Impact on Flares and Other Outcomes
    Location: Poster Hall
    Abstract Poster Presenter: Irene Altabas Gonzalez, MD – Complejo Hospitalario de Vigo
    Systemic lupus erythematosus (SLE)
  • Tuesday, Nov 14th
    9:00 AM – 11:00 AM PT
    2265: Lupus Damage Index Revision - Item Generation and Reduction Phase
    Location: Poster Hall
    Abstract Poster Presenter: Burak Kundakci, PhD, MSc – University of Manchester
    Systemic lupus erythematosus (SLE)
  • Tuesday, Nov 14th
    9:00 AM – 11:00 AM PT
    2266: Direct Health Care Costs Differ by SLE Autoantibody Machine Learning Clusters in an International Inception
    Location: Poster Hall
    Abstract Poster Presenter: May Choi, MD, FRCPC, MPH – University of Calgary
    Systemic lupus erythematosus (SLE)
  • Tuesday, Nov 14th
    9:00 AM – 11:00 AM PT
    2267: Explainable Machine Learning to Predict Hospitalized Infection in Patients with Systemic Lupus Erythematosus
    Location: Poster Hall
    Abstract Poster Presenter: Hsin-Hua Chen, MD, PhD – Taichung Veterans General Hospital
    Systemic lupus erythematosus (SLE)
  • Tuesday, Nov 14th
    9:00 AM – 11:00 AM PT
    2268: Mental Illness and Outcomes of COVID-19 in Patients with Systemic Lupus Erythematosus: A Global Multicenter Cohort Study
    Location: Poster Hall
    Abstract Poster Presenter: Hsin-Hua Chen, MD, PhD – Taichung Veterans General Hospital
    Systemic lupus erythematosus (SLE)
  • Tuesday, Nov 14th
    9:00 AM – 11:00 AM PT
    2269: Evaluating Global Patterns in Treatment and Prevalence of Glucocorticoid Related Comorbidities in Systemic Lupus Erythematosus: An International Study
    Location: Poster Hall
    Abstract Poster Presenter: Chris Wincup, MBBS, BSc, MRCP – King's College Hospital
    Systemic lupus erythematosus (SLE)
  • Tuesday, Nov 14th
    9:00 AM – 11:00 AM PT
    2270: Factors Associated with Discordance Between Patient and Physician Perception of Disease Activity Among Patients with Systemic Lupus Erythematosus: An International Collaborative Study
    Location: Poster Hall
    Abstract Poster Presenter: Chris Wincup, MBBS, BSc, MRCP – King's College Hospital
    Systemic lupus erythematosus (SLE)
  • Tuesday, Nov 14th
    9:00 AM – 11:00 AM PT
    2271: Longitudinal Changes in Type 1 & Type 2 SLE Activity
    Location: Poster Hall
    Abstract Poster Presenter: Amanda M. Eudy, PhD – Duke University
    Systemic lupus erythematosus (SLE)
  • Tuesday, Nov 14th
    9:00 AM – 11:00 AM PT
    2272: Age and Race-Based Differences in Emergency Department Utilization for Systemic Lupus Erythematosus in the United States
    Location: Poster Hall
    Abstract Poster Presenter: Rashmi Dhital, MD – UC San Diego
    Systemic lupus erythematosus (SLE)
  • Tuesday, Nov 14th
    9:00 AM – 11:00 AM PT
    2273: Predicting SLE Disease Activity with Blood Biomarkers: A Step Towards Precision Medicine
    Location: Poster Hall
    Abstract Poster Presenter: Vasileios Kyttaris, MD, PhD – BIDMC
    Systemic lupus erythematosus (SLE)
  • Tuesday, Nov 14th
    9:00 AM – 11:00 AM PT
    2274: Lupus Low Disease Activity State as an Attainable Target in Lupus Nephritis Associated with Reduced Risk of Relapse
    Location: Poster Hall
    Abstract Poster Presenter: Chiu Wai Shirley Chan, MBBS – Division of Rheumatology and Clinial Immunology, Department of Medicine, the University of Hong Kong
    Systemic lupus erythematosus (SLE)
  • Tuesday, Nov 14th
    9:00 AM – 11:00 AM PT
    2275: Lupus Low Disease Activity State Ameliorates the Poor Prognosis in Lupus Nephritis Patients with anti-Sm Autoantibody
    Location: Poster Hall
    Abstract Poster Presenter: Chiu Wai Shirley Chan, MBBS – Division of Rheumatology and Clinial Immunology, Department of Medicine, the University of Hong Kong
    Systemic lupus erythematosus (SLE)
  • Tuesday, Nov 14th
    9:00 AM – 11:00 AM PT
    2276: Patient Reported Impact of Lupus on Quality of Life
    Location: Poster Hall
    Abstract Poster Presenter: Elizabeth Luce, BS – MyHealthTeam
    Systemic lupus erythematosus (SLE)
  • Tuesday, Nov 14th
    9:00 AM – 11:00 AM PT
    2277: Patients with Systemic Lupus Erythematosus: A Comparative Study Between Two Large, Multi-centric, Spanish and Argentinian Registers, Focused on Outcomes Differences
    Location: Poster Hall
    Abstract Poster Presenter: Iñigo Rua Figueroa, MD – Hospital de Gran Canaria Doctor Negrin
    Systemic lupus erythematosus (SLE)
  • Tuesday, Nov 14th
    9:00 AM – 11:00 AM PT
    2278: Pregnancy in Connective Tissue Diseases: A 30 Year Follow-up Study of 465 Pregnancies from a Spanish Monocentric Registry
    Location: Poster Hall
    Abstract Poster Presenter: Cristiana Sieiro Santos, MD – Complejo Asistencial Universitario de León
    Systemic lupus erythematosus (SLE)
  • Tuesday, Nov 14th
    9:00 AM – 11:00 AM PT
    2279: Sociodemographic Features, Health-Related Quality of Life (HRQoL), Previous General Self-Efficacy and Corticosteroids (CS) Are Associated with General Self-Efficacy in Systemic Lupus Erythematosus (SLE) Patients. Data from a Prevalent Latin American Lupus Cohort
    Location: Poster Hall
    Abstract Poster Presenter: Manuel Ugarte-Gil, MD, MSc – Universidad Cientifica del Sur
    Systemic lupus erythematosus (SLE)
  • Tuesday, Nov 14th
    9:00 AM – 11:00 AM PT
    2280: The LFA-REAL Clinician Reported Outcome Predicts Damage in Patients with Systemic Lupus Erythematosus (SLE). Data from a Prevalent Latin American Lupus Cohort
    Location: Poster Hall
    Abstract Poster Presenter: Manuel Ugarte-Gil, MD, MSc – Universidad Cientifica del Sur
    Systemic lupus erythematosus (SLE)
  • Tuesday, Nov 14th
    9:00 AM – 11:00 AM PT
    2281: Epidemiology and Risk of Brain Abscess in Patients with Systemic Lupus Erythematosus in Taiwan: A Nationwide Population-based Study
    Location: Poster Hall
    Abstract Poster Presenter: KE-HUNG LIN, -None- – Taipei Medical University Hospital
    Systemic lupus erythematosus (SLE)
  • Tuesday, Nov 14th
    9:00 AM – 11:00 AM PT
    2282: Increased Risk of Systemic Lupus Erythematosus Flare After COVID-19
    Location: Poster Hall
    Abstract Poster Presenter: Arthur Mageau, MD, MSc – Université Paris Cité
    Systemic lupus erythematosus (SLE)
  • Tuesday, Nov 14th
    9:00 AM – 11:00 AM PT
    2283: Anti-SARS-CoV-2 Vaccination Among Patients Living with Systemic Lupus Erythematosus in Sweden: Coverage and Clinical Effectiveness
    Location: Poster Hall
    Abstract Poster Presenter: Arthur Mageau, MD, MSc – Université Paris Cité
    Systemic lupus erythematosus (SLE)
  • Tuesday, Nov 14th
    9:00 AM – 11:00 AM PT
    2284: Effect of Air Pollutant Exposure on Disease Activity of Systemic Lupus Erythematous: A Prospective Longitudinal Study from Korea
    Location: Poster Hall
    Abstract Poster Presenter: Ji-Hyoun Kang, MD – Chonnam National University Hospital
    Systemic lupus erythematosus (SLE)
  • Tuesday, Nov 14th
    9:00 AM – 11:00 AM PT
    2285: Vaccine Uptake in Women with Systemic Lupus Erythematosus (SLE) - Study Update
    Location: Poster Hall
    Abstract Poster Presenter: J. Patricia Dhar, MD – Ascension St. John Hospital and Wayne State Univeristy School of Medicine
    Systemic lupus erythematosus (SLE)
  • Tuesday, Nov 14th
    9:00 AM – 11:00 AM PT
    2286: Systemic Lupus Erythematosus and Functional Work Disability: A Qualitative Perspective Using a Work Disability Prevention Approach
    Location: Poster Hall
    Abstract Poster Presenter: Zahi Touma, MD, PhD – University of Toronto
    Systemic lupus erythematosus (SLE)
  • Tuesday, Nov 14th
    9:00 AM – 11:00 AM PT
    2287: Mental Health of Lupus Erythematosus Patients Managed in an Academic Safety-Net Clinic
    Location: Poster Hall
    Abstract Poster Presenter: Reina Gonzalez, MD – PHSU
    Systemic lupus erythematosus (SLE)
  • Tuesday, Nov 14th
    9:00 AM – 11:00 AM PT
    2288: Scoping Literature Review and Focus Groups Interviews to Identify Candidate Domains for the SLE OMERACT Core Domain Set
    Location: Poster Hall
    Abstract Poster Presenter: Wils Nielsen, PhD – University of Toronto
    Systemic lupus erythematosus (SLE)
  • Tuesday, Nov 14th
    9:00 AM – 11:00 AM PT
    2289: Short and Long Term Outcomes of Patients with Pure Membranous Lupus Nephritis Compared to Patients with Proliferative Disease
    Location: Poster Hall
    Abstract Poster Presenter: Fadi Kharouf, MD – University Health Network and University of Toronto, Toronto, ON, Canada
    Systemic lupus erythematosus (SLE)
  • Tuesday, Nov 14th
    9:00 AM – 11:00 AM PT
    2290: Association of Mycophenolate and Azathioprine Use with Cognitive Function in Systemic Lupus Using a Bayesian Longitudinal Item-response Theory Model
    Location: Poster Hall
    Abstract Poster Presenter: Chrisanna Dobrowolski, MD, MS – Icahn School of Medicine at Mount Sinai
    Systemic lupus erythematosus (SLE)
  • Tuesday, Nov 14th
    9:00 AM – 11:00 AM PT
    2291: Therapeutic Drug Monitoring (TDM) of Hydroxychloroquine in Whole Blood: Analysis of over 10,000 Patient Results Using Lab Developed Liquid Chromatography Tandem Mass Spectrometry
    Location: Poster Hall
    Abstract Poster Presenter: Jane Yang, MD – LabCorp
    Systemic lupus erythematosus (SLE)
  • Tuesday, Nov 14th
    9:00 AM – 11:00 AM PT
    2292: Is Machine Learning Useful to Predict Flare During Pregnancy in Systemic Lupus Erythematosus?
    Location: Poster Hall
    Abstract Poster Presenter: Elena Elefante, MD – Rheumatology Unit, Department of clinical and experimental medicine, University of Pisa
    Systemic lupus erythematosus (SLE)
  • Tuesday, Nov 14th
    9:00 AM – 11:00 AM PT
    2293: Recurrent Intracellular Infections Cluster Together in Patients of SLE with Lymphopenia and Active Disease
    Location: Poster Hall
    Abstract Poster Presenter: Rudrarpan Chatterjee, MD, MBBS, DM – Sanjay Gandhi Postgraduate Institute of Medical Sciences, Lucknow.
    Systemic lupus erythematosus (SLE)
  • Tuesday, Nov 14th
    9:00 AM – 11:00 AM PT
    2294: Organ Damage Progression in Systemic Lupus Erythematosus: An Analysis of the SLE Prospective Observational Cohort Study (SPOCS)
    Location: Poster Hall
    Abstract Poster Presenter: Richard Furie, MD – Northwell Health
    Systemic lupus erythematosus (SLE)
  • Tuesday, Nov 14th
    9:00 AM – 11:00 AM PT
    2295: Predictors of Adherence to Cervical Cancer Screening Guidelines Among Patients with Systemic Lupus Erythematosus
    Location: Poster Hall
    Abstract Poster Presenter: Lindsay Cho, MD, MSc – University of British Columbia
    Systemic lupus erythematosus (SLE)
  • Tuesday, Nov 14th
    9:00 AM – 11:00 AM PT
    2296: Association Between EQ-5D-5L and SLEDAI Scores in Patients with Systemic Lupus Erythematosus in the United States and Europe: A Real-world Survey
    Location: Poster Hall
    Abstract Poster Presenter: Ebuwa Igho-Osagie, DrPH – Merck & Co. Inc.
    Systemic lupus erythematosus (SLE)
  • Tuesday, Nov 14th
    9:00 AM – 11:00 AM PT
    2297: Interferon-α as a Biomarker to Predict Flares in Lupus Nephritis
    Location: Poster Hall
    Abstract Poster Presenter: Laura Whittall Garcia, MD – University Health Network
    Systemic lupus erythematosus (SLE)
  • Tuesday, Nov 14th
    9:00 AM – 11:00 AM PT
    2298: SLE Patients Are at High Risk for Tuberculosis Infection: Data from a Lupus Center of an Endemic Country
    Location: Poster Hall
    Abstract Poster Presenter: Fernanda Lopes, MD – University of São Paulo
    Systemic lupus erythematosus (SLE)
  • Tuesday, Nov 14th
    9:00 AM – 11:00 AM PT
    2299: Medication-related Hospitalizations in Systemic Lupus Erythematosus
    Location: Poster Hall
    Abstract Poster Presenter: Michele Stanciu, MD – McGill University
    Systemic lupus erythematosus (SLE)
  • Tuesday, Nov 14th
    9:00 AM – 11:00 AM PT
    2300: Outcomes of COVID-19 Before and During the Omicron Variant Period in Patients with Systemic Lupus Erythematosus: A Global Multicenter Cohort Study Using the TriNetX Network
    Location: Poster Hall
    Abstract Poster Presenter: Wen-Nan Huang, MD – Taichung Veterans General Hospital, Taiwan
    Systemic lupus erythematosus (SLE)
  • Tuesday, Nov 14th
    9:00 AM – 11:00 AM PT
    2301: Relapse in Japanese Patients with Newly Diagnosed SLE and Its Clinical Characteristics in Daily Clinical Practice: A Single Center Experience in Recent 10 Years
    Location: Poster Hall
    Abstract Poster Presenter: Shuzo Sato, MD, PhD (he/him/his) – Fukushima Medical University
    Systemic lupus erythematosus (SLE)
  • Tuesday, Nov 14th
    9:00 AM – 11:00 AM PT
    2302: Persistently Active Disease in Adult Patients with Childhood Onset Systemic Lupus Erythematosus
    Location: Poster Hall
    Abstract Poster Presenter: Alberta Hoi, MD, PhD – Monash University
    Systemic lupus erythematosus (SLE)
  • Tuesday, Nov 14th
    9:00 AM – 11:00 AM PT
    2303: Are Neuropsychiatric Symptoms in Systemic Lupus Erythematosus (NPSLE) Associated with More Frequent Hospitalizations or Exposure to a Greater Number of Immunosuppressive Medications?
    Location: Poster Hall
    Abstract Poster Presenter: Jaime Vondenberg, DO (she/her/hers) – Cleveland Clinic Foundation
    Systemic lupus erythematosus (SLE)
  • Tuesday, Nov 14th
    9:00 AM – 11:00 AM PT
    2304: Disparity in Healthcare in Systemic Lupus Erythematosus: A Single-Center Study
    Location: Poster Hall
    Abstract Poster Presenter: Anam Nazir (she/her/hers) – The Ottawa Hospital Research Institute
    Systemic lupus erythematosus (SLE)
  • Tuesday, Nov 14th
    9:00 AM – 11:00 AM PT
    2305: Infection Vulnerability in Pregnant Women with and Without Systemic Lupus Erythematosus
    Location: Poster Hall
    Abstract Poster Presenter: Hiba Ahmed, MD (she/her/hers) – Tawam Hospital
    Systemic lupus erythematosus (SLE)
  • Tuesday, Nov 14th
    9:00 AM – 11:00 AM PT
    2306: Changes in Rheumatology Disease Measures After Initiation of Belimumab Treatment in Patients with Systemic Lupus Erythematosus
    Location: Poster Hall
    Abstract Poster Presenter: Bernie Rubin, DO, MPH – GSK
    Systemic lupus erythematosus (SLE)
  • Tuesday, Nov 14th
    9:00 AM – 11:00 AM PT
    2307: Comparing Social Vulnerability Index to Area Deprivation Index to Patient Outcomes in SLE and Glucocorticoid Utilization
    Location: Poster Hall
    Abstract Poster Presenter: Avira Som, MD – Washington University School of Medicine in St. Louis
    Systemic lupus erythematosus (SLE)
  • Tuesday, Nov 14th
    9:00 AM – 11:00 AM PT
    2308: The Association Between Poverty and SLE Disease Burden: Experiences from a Saint Lucian Cohort
    Location: Poster Hall
    Abstract Poster Presenter: Amanda King, MBBS, FRCP, FACR – Bay Medical Centre
    Systemic lupus erythematosus (SLE)
  • Tuesday, Nov 14th
    9:00 AM – 11:00 AM PT
    2309: Enterococcus Gallinarum Prevalence in Patients with Systemic Lupus Erythematosus
    Location: Poster Hall
    Abstract Poster Presenter: Oscar E. Alvarez-González, MD – Hospital Universitario "Dr. José Eleuterio González", Universidad Autónoma de Nuevo León
    Systemic lupus erythematosus (SLE)
  • Tuesday, Nov 14th
    9:00 AM – 11:00 AM PT
    2310: Machine Learning Approaches for Prediction of Renal Flares in Systemic Lupus Erythematosus: Knowledge-Driven Models Outperformed Data-Driven Models
    Location: Poster Hall
    Abstract Poster Presenter: Dionysis Nikolopoulos, MD – Karolinska Institutet and Karolinska University Hospital, Division of Rheumatology, Department of Medicine Solna
    Systemic lupus erythematosus (SLE)
  • Tuesday, Nov 14th
    9:00 AM – 11:00 AM PT
    2311: Effect on Lupus Outcomes of the Protective Allele at rs1876453 in the Complement Receptor 2 Gene
    Location: Poster Hall
    Abstract Poster Presenter: Susan Boackle, MD – Susan Boackle Childress, M.D., Medical and Scientific Consulting
    Systemic lupus erythematosus (SLE)
  • Tuesday, Nov 14th
    9:00 AM – 11:00 AM PT
    2312: Fungal Infections in Hospitalized Patients of Systemic Lupus Erythematosus: A Nationwide Cohort Analysis
    Location: Poster Hall
    Abstract Poster Presenter: Saman Tanveer, MD, MBBS (she/her/hers) – John H. Stroger Jr. Hospital of Cook County
    Systemic lupus erythematosus (SLE)
  • Tuesday, Nov 14th
    9:00 AM – 11:00 AM PT
    2313: Utilization of Palliative Care in Hospitalized Patients with Systemic Lupus Erythematosus: A Nationwide Cohort Analysis
    Location: Poster Hall
    Abstract Poster Presenter: Saman Tanveer, MD, MBBS (she/her/hers) – John H. Stroger Jr. Hospital of Cook County
    Systemic lupus erythematosus (SLE)
  • Tuesday, Nov 14th
    9:00 AM – 11:00 AM PT
    2314: Comparison of Disease Severity and Outcomes in Adolescent-Onset and Young Adult-Onset Systemic Lupus Erythematosus
    Location: Poster Hall
    Abstract Poster Presenter: Emma Materne, MD (she/her/hers) – Massachusetts General Hospital
    Systemic lupus erythematosus (SLE)
  • Tuesday, Nov 14th
    9:00 AM – 11:00 AM PT
    2315: Assessing Lupus Disease Activity Following the Onset of End-Stage Kidney Disease Within a Single Tertiary Centre in South London
    Location: Poster Hall
    Abstract Poster Presenter: Samir Patel, MBBS – King's College London
    Systemic lupus erythematosus (SLE)
  • Tuesday, Nov 14th
    9:00 AM – 11:00 AM PT
    2316: Effect of SARS-CoV2 Infection on Disease Flares in Patients with Systemic Lupus Erythematosus: A Case-control Study
    Location: Poster Hall
    Abstract Poster Presenter: Chi Chiu Mok, MD, FRCP – Tuen Mun Hospital
    Systemic lupus erythematosus (SLE)
  • Tuesday, Nov 14th
    9:00 AM – 11:00 AM PT
    2317: Effect of SLE-DAS Remission on Quality of Life in Patients with Systemic Lupus Erythematosus: A Cross-sectional Validation Study
    Location: Poster Hall
    Abstract Poster Presenter: Fung Lam, MSc, MBChB, MRCP – POH
    Systemic lupus erythematosus (SLE)
  • Tuesday, Nov 14th
    9:00 AM – 11:00 AM PT
    2318: The Association Between Systemic Lupus Erythematosus (SLE) and Bone Mineral Density (BMD) Polygenic Risk Scores with Lumbar Spine BMD Z-score: A Retrospective Cohort Study
    Location: Poster Hall
    Abstract Poster Presenter: Linda Hiraki, MD, FRCPC, ScD – The Hospital for Sick Children
    Systemic lupus erythematosus (SLE)
  • Tuesday, Nov 14th
    9:00 AM – 11:00 AM PT
    2319: Changes in the Causes and Predictors of Lupus Mortality in Spain Through the Last Decades: Data from the RELESSER Registry
    Location: Poster Hall
    Abstract Poster Presenter: Jaime Calvo Alén, MD, PhD – Hospital Universitario Araba
    Systemic lupus erythematosus (SLE)
  • Tuesday, Nov 14th
    9:00 AM – 11:00 AM PT
    2320: Predicting Remission and Low Disease Activity Attainment in Patients with Systemic Lupus Erythematosus
    Location: Poster Hall
    Abstract Poster Presenter: Ioannis Parodis, MD, PhD – Karolinska Institutet
    Systemic lupus erythematosus (SLE)
  • Tuesday, Nov 14th
    9:00 AM – 11:00 AM PT
    2321: Does the Perspective of SLE Patients Match the Expert Opinion and Definitions of Remission and Low Disease Activity State? Prospective Analysis of 500 Patients from a Spanish Multicenter Cohort
    Location: Poster Hall
    Abstract Poster Presenter: Coral Mourino Rodriguez, RN – Complejo Hospitalario Universitario de Vigo. IRIDIS (Investigation in Rheumatology and Immune-Mediated Diseases) Group, Galicia Sur Health Research Institute
    Systemic lupus erythematosus (SLE)
  • Tuesday, Nov 14th
    9:00 AM – 11:00 AM PT
    2322: Identifying SLE Patients with Depression Using a Zero-Inflated Hidden Markov Model and Predicting Factors Associated with Transition from a Non-depressed State to a Depressed State
    Location: Poster Hall
    Abstract Poster Presenter: Juan Pablo Diaz Martinez, PhD – UHN
    Systemic lupus erythematosus (SLE)
  • Tuesday, Nov 14th
    9:00 AM – 11:00 AM PT
    2323: An Electronic Health Record-Based Algorithm for Predicting Systemic Lupus Erythematosus Flares: Integrating Clinical Factors and Social Determinants of Health
    Location: Poster Hall
    Abstract Poster Presenter: Lixia Yao, PhD – Polygon Health Analytics LLC
    Systemic lupus erythematosus (SLE)
  • Tuesday, Nov 14th
    9:00 AM – 11:00 AM PT
    2324: Leveraging ChatGPT for Real-World Systematic Lupus Erythematosus Data Curation from Electronic Health Records: A Feasibility Study
    Location: Poster Hall
    Abstract Poster Presenter: Lixia Yao, PhD – Polygon Health Analytics LLC
    Systemic lupus erythematosus (SLE)
  • Tuesday, Nov 14th
    9:00 AM – 11:00 AM PT
    2325: Longitudinal ANA Titers in SLE and ANA-associated Rheumatic Diseases
    Location: Poster Hall
    Abstract Poster Presenter: Emily Littlejohn, DO, MPH – Cleveland Clinic
    Systemic lupus erythematosus (SLE)
  • Tuesday, Nov 14th
    9:00 AM – 11:00 AM PT
    2326: Efficacy and Safety of Voclosporin in Patients with Proteinuria > 2 G/g
    Location: Poster Hall
    Abstract Poster Presenter: Vanessa Birardi, PharmD – Aurinia Pharmaceuticals Inc
    Systemic lupus erythematosus (SLE)
  • Tuesday, Nov 14th
    9:00 AM – 11:00 AM PT
    2327: Hydroxychloroquine Improves Low Complement Levels
    Location: Poster Hall
    Abstract Poster Presenter: Michelle Petri, MD, MPH (she/her/hers) – Johns Hopkins University School of Medicine
    Systemic lupus erythematosus (SLE)
  • Tuesday, Nov 14th
    9:00 AM – 11:00 AM PT
    2328: Deucravacitinib, an Oral, Allosteric, Tyrosine Kinase 2 (TYK2) Inhibitor, in Patients with Active Systemic Lupus Erythematosus: Patient-Reported Outcomes in a Phase 2 Trial
    Location: Poster Hall
    Abstract Poster Presenter: Marta Mosca, MD, PhD – University of Pisa
    Systemic lupus erythematosus (SLE)
  • Tuesday, Nov 14th
    9:00 AM – 11:00 AM PT
    2329: AMTX-100, a Nuclear Transport Inhibitor, Attenuates Inflammatory Cytokine Production in vitro and Following UV Mediated Skin Inflammation in a Mouse Model of Cutaneous Lupus Erythematosus in vivo
    Location: Poster Hall
    Abstract Poster Presenter: Xizhang Sun, PhD – University of Washington
    Systemic lupus erythematosus (SLE)
  • Tuesday, Nov 14th
    9:00 AM – 11:00 AM PT
    2330: Disease-Related Outcomes of Cognitive Behavioral Therapy in Randomized Control Trial for Youth with Childhood-onset SLE: A Secondary Analysis
    Location: Poster Hall
    Abstract Poster Presenter: Andrea Knight, MD, MSCE – Hospital for Sick Children
    Systemic lupus erythematosus (SLE)
  • Tuesday, Nov 14th
    9:00 AM – 11:00 AM PT
    2331: Molecular Predictors of Treatment Response in Two Trials of Abatacept in Systemic Lupus Erythematosus
    Location: Poster Hall
    Abstract Poster Presenter: Kevin Thomas, BSc – University of Oklahoma Health Sciences Center
    Systemic lupus erythematosus (SLE)
  • Tuesday, Nov 14th
    9:00 AM – 11:00 AM PT
    2332: Dapirolizumab Pegol Efficacy by Subgroups in Patients with SLE: A Post Hoc Analysis of Phase 2b Clinical Trial Data
    Location: Poster Hall
    Abstract Poster Presenter: Anca Askanase, MD, MPH – Columbia University Medical Center
    Systemic lupus erythematosus (SLE)
  • Tuesday, Nov 14th
    9:00 AM – 11:00 AM PT
    2333: Dapirolizumab Pegol Impacts Important Immunologic Pathways in SLE: Pharmacodynamic Analysis of B Cell and Type I Interferon Pathways from a Phase 2b Trial
    Location: Poster Hall
    Abstract Poster Presenter: Christian Stach, MD – UCB Biosciences GmbH
    Systemic lupus erythematosus (SLE)
  • Tuesday, Nov 14th
    9:00 AM – 11:00 AM PT
    2334: Remission Attainment in Patients with Systemic Lupus Erythematosus Treated with Anifrolumab Compared with Placebo over a 4-Year Period
    Location: Poster Hall
    Abstract Poster Presenter: Eric Morand, MD, PhD – Monash University
    Systemic lupus erythematosus (SLE)
  • Tuesday, Nov 14th
    9:00 AM – 11:00 AM PT
    2335: Defining a Basket Population for ANA+ Arthritis Trials
    Location: Poster Hall
    Abstract Poster Presenter: Ed Vital, MD – University of Leeds
    Systemic lupus erythematosus (SLE)
  • Tuesday, Nov 14th
    9:00 AM – 11:00 AM PT
    2336: Identification of Urine Metabolites Linked to Disease Activity That Are Modulated by Anifrolumab in a Phase 2 LN Trial Using Untargeted Metabolomics Analysis
    Location: Poster Hall
    Abstract Poster Presenter: David R W Jayne, MD – University of Cambridge
    Systemic lupus erythematosus (SLE)
  • Tuesday, Nov 14th
    9:00 AM – 11:00 AM PT
    2337: Safety and Tolerability of NIM-1324, an Oral, Once-daily LANCL2 Agonist, in a Randomized, Double-Blind, Placebo-Controlled Phase 1 Study in Normal Healthy Volunteers
    Location: Poster Hall
    Abstract Poster Presenter: Andrew Leber, PhD – NIMML Institute
    Systemic lupus erythematosus (SLE)
  • Tuesday, Nov 14th
    9:00 AM – 11:00 AM PT
    2338: Results of Single-Arm, Phase 1b Study of Anti-C1q Treatment (ANX009) Show That the Classical Pathway Is a Key Driver of Complement Activation and Consumption in Patients with Active Lupus Nephritis
    Location: Poster Hall
    Abstract Poster Presenter: Yaisa Andrews Zwilling, PhD – Annexon Biosciences
    Systemic lupus erythematosus (SLE)
  • Tuesday, Nov 14th
    9:00 AM – 11:00 AM PT
    2339: Fragility of Randomized Clinical Trials of Systemic Lupus Erythematosus and Lupus Nephritis Therapies
    Location: Poster Hall
    Abstract Poster Presenter: Gabriel Figueroa-Parra, MD – Mayo Clinic
    Systemic lupus erythematosus (SLE)
  • Tuesday, Nov 14th
    9:00 AM – 11:00 AM PT
    2340: Multi-targeted Therapy Better in Achieving Complete Response in Lupus Nephritis: A Systematic Review and Meta-analysis
    Location: Poster Hall
    Abstract Poster Presenter: Omer Pamuk, MD – University Hospitals Cleveland Medical Center
    Systemic lupus erythematosus (SLE)
  • Tuesday, Nov 14th
    9:00 AM – 11:00 AM PT
    2341: Spanish National Registry of Belimumab in Patients with Systemic Lupus Erythematosus
    Location: Poster Hall
    Abstract Poster Presenter: Vicente Aldasoro Caceres, MD – Hospital Universitario de Navarra
    Systemic lupus erythematosus (SLE)
  • Tuesday, Nov 14th
    9:00 AM – 11:00 AM PT
    2342: Modulation of B Cell and Interferon Pathways by Ianalumab in Patients with Systemic Lupus Erythematosus: Findings from a Phase 2 Clinical Trial
    Location: Poster Hall
    Abstract Poster Presenter: Isabelle Isnardi, PhD – Novartis
    Systemic lupus erythematosus (SLE)
  • Tuesday, Nov 14th
    9:00 AM – 11:00 AM PT
    2343: Hydroxychloroquine Discontinuation in the Real World: Reasons, Predictive Factors and Clinical Implications
    Location: Poster Hall
    Abstract Poster Presenter: Eduardo Mantovani Cardoso, MD – Beth Israel Deaconess Medical Center
    Systemic lupus erythematosus (SLE)
  • Tuesday, Nov 14th
    9:00 AM – 11:00 AM PT
    2345: Paired Kidney Biopsies from the AURORA 2 Study of Voclosporin in Active Lupus Nephritis
    Location: Poster Hall
    Abstract Poster Presenter: Ernie Yap, MD (he/him/his) – Aurinia Pharmaceuticals
    Systemic lupus erythematosus (SLE)
  • Tuesday, Nov 14th
    9:00 AM – 11:00 AM PT
    2346: SLE Medication Usage and Organ Damage Among Adult SLE Patients with SLE Treated with Belimumab (BEL): Pooled Data from Three Open-Label Extension Studies over 11+ Years
    Location: Poster Hall
    Abstract Poster Presenter: Zahi Touma, MD, PhD – University of Toronto
    Systemic lupus erythematosus (SLE)
  • Tuesday, Nov 14th
    9:00 AM – 11:00 AM PT
    2347: Efficacy of Belimumab in Patients with Systemic Lupus Erythematosus by Race and Ethnicity: A Large Post Hoc Integrated Analysis of Five Clinical Trials
    Location: Poster Hall
    Abstract Poster Presenter: Saira Sheikh, MD – University of North Carolina at Chapel Hill
    Systemic lupus erythematosus (SLE)
  • Tuesday, Nov 14th
    9:00 AM – 11:00 AM PT
    2348: Incidence of Infections Among Adult Patients with SLE Treated with Belimumab (BEL): Pooled Data from Three Open-Label Extension Studies over 11+ Years
    Location: Poster Hall
    Abstract Poster Presenter: Jinoos Yazdany, MD, MPH – UCSF
    Systemic lupus erythematosus (SLE)
  • Tuesday, Nov 14th
    9:00 AM – 11:00 AM PT
    2349: Selection of the Dose for Subcutaneous Administration to Non-Japanese Subjects and Intravenous Administration to Japanese Subjects in the First-in-Human Study of DS-7011a, an Anti-TLR7 Monoclonal Antibody for the Treatment of Systemic Lupus Erythematosus
    Location: Poster Hall
    Abstract Poster Presenter: Li Zhang, MD, PhD – Daiichi Sankyo
    Systemic lupus erythematosus (SLE)
  • Tuesday, Nov 14th
    9:00 AM – 11:00 AM PT
    2350: Upregulation of Both APRIL and BAFF in Systemic Lupus Erythematosus Suggests Non-Redundant Roles, Further Revealed by Dual Inhibition with Povetacicept (ALPN-303; TACI vTD-Fc)
    Location: Poster Hall
    Abstract Poster Presenter: Tiffany Blair, PhD – Alpine Immune Sciences, Inc.
    Systemic lupus erythematosus (SLE)
  • Tuesday, Nov 14th
    9:00 AM – 11:00 AM PT
    2351: Health Outcomes Among Patients (Pts) with SLE Initiating Belimumab (BEL) with and Without the Use of Immunosuppressants in the Previous 2 Years
    Location: Poster Hall
    Abstract Poster Presenter: Karen Worley, PhD, MS – GlaxoSmithKline, US Value, Evidence and Outcomes
    Systemic lupus erythematosus (SLE)
  • Tuesday, Nov 14th
    11:30 AM – 11:40 AM PT
    2427: Degranulating PR3+ Myeloid Cells Characterize Proliferative Lupus Nephritis
    Location: Exhibit Hall A-B
    Plenary Presenter: Alessandra Ida Celia, MD (she/her/hers) – Sapienza University of Rome
    Systemic lupus erythematosus (SLE)
  • Tuesday, Nov 14th
    2:00 PM – 3:30 PM PT
    14T157: Abstracts: SLE – Animal Models (2443–2448)
    Location: Room 26A-B
    Abstract Moderator: Paul Hoover, MD, PhD – Brigham and Women's Hospital
    Abstract Moderator: Carla Cuda, PhD – Northwestern University
    Systemic lupus erythematosus (SLE)
  • Tuesday, Nov 14th
    2:00 PM – 3:30 PM PT
    14T158: Abstracts: SLE – Treatment II: Nonrenal (2485–2490)
    Location: Ballroom 20D
    Abstract Moderator: Graciela Alarcón, MD, MPH (she/her/hers) – The University of Alabama at Birmingham
    Abstract Moderator: Kimberly Trotter, MD – University of Chicago
    Systemic lupus erythematosus (SLE)
  • Tuesday, Nov 14th
    2:00 PM – 2:10 PM PT
    2443: Blockade of OX40/OX40L Signaling Using anti-OX40L Ameliorates Systemic Lupus Erythematosus
    Location: Room 26A-B
    Presenting Author: Junpeng Zhao, PhD – Peking Union Medical College, Hospital for Skin Diseases, Institute of Dermatology, Chinese Academy of Medical Sciences and Peking Union Medical College
    Systemic lupus erythematosus (SLE)
  • Tuesday, Nov 14th
    2:00 PM – 2:10 PM PT
    2485: Comparative Risk of Serious Psychiatric Events with Belimumab versus Oral Immunosuppressant Use in Patients with Systemic Lupus Erythematosus
    Location: Ballroom 20D
    Presenting Author: April Jorge, MD – Massachusetts General Hospital
    Systemic lupus erythematosus (SLE)
  • Tuesday, Nov 14th
    2:00 PM – 2:10 PM PT
    2497: Factors Influencing Time to Diagnosis in U.S. Patients with Systemic Lupus Erythematosus
    Location: Room 24A-C
    Presenting Author: Joy Buie, RN, PhD, MSc – Lupus Foundation of America
    Systemic lupus erythematosus (SLE)
  • Tuesday, Nov 14th
    2:15 PM – 2:25 PM PT
    2444: Development of Engineered Smith-Specific Regulatory T Cells to Treat Lupus Nephritis
    Location: Room 26A-B
    Presenting Author: Eric Morand, MD, PhD – Monash University
    Systemic lupus erythematosus (SLE)
  • Tuesday, Nov 14th
    2:15 PM – 2:25 PM PT
    2486: Should SLE Patients Entering Clinical Trials Be Required to Have at Least One BILAG a And/or Two BILAG B Scores?
    Location: Ballroom 20D
    Presenting Author: Ewa Olech, MD (she/her/hers) – Rheumatology Consultants, PLLC
    Systemic lupus erythematosus (SLE)
  • Tuesday, Nov 14th
    2:30 PM – 2:40 PM PT
    2445: Targeting of Endothelial Dysfunction in Lupus Nephritis: Effect on Human Renal Endothelial Cell Gene Expression and Outcomes in Murine Lupus Nephritis
    Location: Room 26A-B
    Presenting Author: Dayvia Russell, BS – Ralph H. Johnson VA Medical Center
    Systemic lupus erythematosus (SLE)
  • Tuesday, Nov 14th
    2:30 PM – 2:40 PM PT
    2487: Phase 2 Safety and Efficacy of Subcutaneous (s.c.) Dose Ianalumab (VAY736; Anti-BAFFR mAb) Administered Monthly over 28 Weeks in Patients with Systemic Lupus Erythematosus (SLE) of Moderate-to-Severe Activity
    Location: Ballroom 20D
    Presenting Author: Nan Shen, MD, PhD – Shanghai Jiang Tong University School of Medicine
    Systemic lupus erythematosus (SLE)
  • Tuesday, Nov 14th
    2:45 PM – 2:55 PM PT
    2446: Intermittent Fasting Attenuates Cognitive Dysfunction in Murine Systemic Lupus Erythematosus
    Location: Room 26A-B
    Presenting Author: Yi Feng, MD – Department of Rheumatology, Nanfang Hospital, Southern Medical University
    Systemic lupus erythematosus (SLE)
  • Tuesday, Nov 14th
    2:45 PM – 2:55 PM PT
    2488: Efficacy and Safety of ABBV-599 High Dose (Elsubrutinib 60 mg and Upadacitinib 30 mg) and Upadacitinib Monotherapy for the Treatment of Systemic Lupus Erythematosus: A Phase 2, Double-blind, Placebo-controlled Trial
    Location: Ballroom 20D
    Presenting Author: Joan Merrill, MD – Oklahoma Medical Research Foundation
    Systemic lupus erythematosus (SLE)
  • Tuesday, Nov 14th
    2:45 PM – 2:55 PM PT
    2500: Suicidal Ideation and Self-Efficacy in Systemic Lupus Erythematosus: Georgians Organized Against Lupus (GOAL) Cohort
    Location: Room 24A-C
    Presenting Author: Charmayne Dunlop-Thomas, MS, MPH – Emory University
    Systemic lupus erythematosus (SLE)
  • Tuesday, Nov 14th
    3:00 PM – 3:10 PM PT
    2447: Interleukin-6 Activates Glial Cells and Induces Cognitive Dysfunction in Murine Neuropsychiatric Lupus
    Location: Room 26A-B
    Presenting Author: Chaim Putterman, MD – Albert Einstein College of Medicine
    Systemic lupus erythematosus (SLE)
  • Tuesday, Nov 14th
    3:00 PM – 3:10 PM PT
    2489: Cutaneous Lupus Erythematosus Disease Area and Severity Index (CLASI) Achievement and Sustained Response with Deucravacitinib, an Oral, Selective, Allosteric Tyrosine Kinase 2 Inhibitor, in a Phase 2 Trial in SLE
    Location: Ballroom 20D
    Presenting Author: Cristina Arriens, MD, MS – Oklahoma Medical Research Foundation
    Systemic lupus erythematosus (SLE)
  • Tuesday, Nov 14th
    3:15 PM – 3:25 PM PT
    2448: UV Light Exposure Induces a Type I Interferon Dependent Activation and Migration of Inflammatory Dendritic Cells to Local Lymph Nodes
    Location: Room 26A-B
    Presenting Author: Xizhang Sun, PhD – University of Washington
    Systemic lupus erythematosus (SLE)
  • Tuesday, Nov 14th
    3:15 PM – 3:25 PM PT
    2490: Safety and Efficacy of Mycophenolate Mofetil in New-onset Systemic Lupus Erythematosus with High Titer of Anti-dsDNA Antibody and Without Major Organ Involvement: A Multicenter Randomized Controlled Trial
    Location: Ballroom 20D
    Presenting Author: Junna Ye, MD – Ruijin Hospital affiliated to Shanghai Jiaotong University School of Medicine
    Systemic lupus erythematosus (SLE)
  • Tuesday, Nov 14th
    3:15 PM – 3:25 PM PT
    2502: Self-Reported Sleep Disorders Among Individuals with Systemic Lupus Erythematosus
    Location: Room 24A-C
    Presenting Author: Patti Katz, PhD (she/her/hers) – UCSF
    Systemic lupus erythematosus (SLE)
  • Tuesday, Nov 14th
    4:00 PM – 5:30 PM PT
    14T177: Abstracts: SLE – Diagnosis, Manifestations, & Outcomes III: Disease Activity (2551–2556)
    Location: Ballroom 20A
    Abstract Moderator: Alberta Hoi, MD, PhD – Monash University
    Abstract Moderator: Zahi Touma, MD, PhD – University of Toronto
    Systemic lupus erythematosus (SLE)
  • Tuesday, Nov 14th
    4:00 PM – 4:10 PM PT
    2551: Remission and Low Disease Activity (LDA) in Patients with SLE Treated with Belimumab (BEL): Results from a Large Integrated Analysis
    Location: Ballroom 20A
    Presenting Author: Ioannis Parodis, MD, PhD – Karolinska Institutet
    Systemic lupus erythematosus (SLE)
  • Tuesday, Nov 14th
    4:15 PM – 4:25 PM PT
    2552: Inflammatory Fibrosis Precedes Loss of Kidney Function in Lupus Nephritis
    Location: Ballroom 20A
    Systemic lupus erythematosus (SLE)
  • Tuesday, Nov 14th
    4:30 PM – 4:40 PM PT
    2553: Prevalence, Determinants and Outcomes of Target Attainment in SLE Patients with Clinically Active Disease in a Large Multinational Prospective Lupus Cohort
    Location: Ballroom 20A
    Presenting Author: Mandana Nikpour, PhD, MBBS – The University of Sydney
    Systemic lupus erythematosus (SLE)
  • Tuesday, Nov 14th
    4:45 PM – 4:55 PM PT
    2554: Validation of a Flare Risk Index Informed by Select Immune Mediators in Systemic Lupus Erythematosus in a Confirmatory Cohort
    Location: Ballroom 20A
    Presenting Author: Melissa Munroe, MD, PhD (she/her/hers) – Oklahoma Medical Research Foundation
    Systemic lupus erythematosus (SLE)
  • Tuesday, Nov 14th
    5:00 PM – 5:10 PM PT
    2555: Cluster Analysis Reveals Subgroups in Patients with Serologically Active Clinically Quiescent Systemic Lupus Erythematosus: Implication for Long-term Prognosis Prediction
    Location: Ballroom 20A
    Presenting Author: Yu Fang Ding, MD (she/her/hers) – Peking Union Medical College
    Systemic lupus erythematosus (SLE)
  • Tuesday, Nov 14th
    5:15 PM – 5:25 PM PT
    2556: End-of-Life in Systemic Lupus Erythematosus Beset by Increased Flares and Higher Treatment Burden: Data from a Prospective Large Multinational Cohort
    Location: Ballroom 20A
    Presenting Author: Jiacai Cho, MBBS, MRCP, MMed – National University Hospital
    Systemic lupus erythematosus (SLE)
  • Wednesday, Nov 15th
    8:00 AM – 8:15 AM PT
    L17: Safety, Tolerability, and Exploratory Efficacy of Afimetoran, a TLR7/8 Inhibitor, in Patients with Cutaneous Lupus Erythematosus: A Phase 1b Randomized, Double-Blind, Placebo-Controlled Study
    Location: Room 6A-B
    Presenting Author: Fareeda Hosein, MD, MBA – BMS
    Systemic lupus erythematosus (SLE)
  • Wednesday, Nov 15th
    8:00 AM – 9:00 AM PT
    15W107: Heterogeneity in Lupus: Lessons from the Autoimmunity Centers of Excellence
    Location: Room 29A-D
    Moderator: Anne Davidson, MBBS, FRACP – Feinstein Institutes for Medical Research
    Moderator: Jeffrey Rice, PhD – National Institute of Allergy and Infectious Diseases (NIH/NIAID)
    Systemic lupus erythematosus (SLE)
     CME: 1 hours
  • Wednesday, Nov 15th
    8:00 AM – 8:15 AM PT
    Effector B Cells in SLE
    Location: Room 29A-D
    Speaker: Iñaki Sanz, MD – Emory University School of Medicine
    Systemic lupus erythematosus (SLE)
  • Wednesday, Nov 15th
    8:15 AM – 8:30 AM PT
    Immune Cells and Secretory Pathways in Human Systemic Lupus Erythematosus
    Location: Room 29A-D
    Speaker: Virginia Pascual, MD – Weill Cornell Medical College
    Systemic lupus erythematosus (SLE)
  • Wednesday, Nov 15th
    8:30 AM – 8:45 AM PT
    In Situ Adaptive Immunity in Human Lupus Nephritis
    Location: Room 29A-D
    Speaker: Marcus Clark, MD – University of Chicago
    Systemic lupus erythematosus (SLE)
  • Wednesday, Nov 15th
    8:45 AM – 9:00 AM PT
    Q&A
    Location: Room 29A-D
    Systemic lupus erythematosus (SLE)
  • Wednesday, Nov 15th
    11:00 AM – 12:30 PM PT
    15W124: Abstracts: SLE – Diagnosis, Manifestations, & Outcomes IV: Outcomes & Comorbidity (2587–2592)
    Location: Room 25A-C
    Abstract Moderator: Emily Smitherman, MD, MS – University of Alabama at Birmingham
    Abstract Moderator: Sean O'Neill, FRACP – University of Sydney and Royal North Shore Hospital, Sydney, Australia
    Systemic lupus erythematosus (SLE)
  • Wednesday, Nov 15th
    11:00 AM – 11:10 AM PT
    2587: Measuring Frailty in SLE: Agreement Among Methods
    Location: Room 25A-C
    Presenting Author: Patti Katz, PhD (she/her/hers) – UCSF
    Systemic lupus erythematosus (SLE)
  • Wednesday, Nov 15th
    11:15 AM – 11:25 AM PT
    2588: Updated Analyses of Cancer Incidence and Risk Factors in a Large International SLE Cohort
    Location: Room 25A-C
    Presenting Author: Christine Peschken, MD, FRCPC, MSc – University of Manitoba
    Systemic lupus erythematosus (SLE)
  • Wednesday, Nov 15th
    11:30 AM – 11:40 AM PT
    2589: Real-World Application of the Pediatric Glucocorticoid Toxicity Index in Children with Systemic Lupus Erythematosus
    Location: Room 25A-C
    Presenting Author: Joyce Chang, MD, MSCE (she/her/hers) – Boston Children's Hospital
    Systemic lupus erythematosus (SLE)
  • Wednesday, Nov 15th
    11:45 AM – 11:55 AM PT
    2590: Association Between Frailty and Readmissions in Hospitalized Patients with Systemic Lupus Erythematosus (SLE)
    Location: Room 25A-C
    Presenting Author: Siddharth Singh – University of California San Diego
    Systemic lupus erythematosus (SLE)
  • Wednesday, Nov 15th
    12:00 PM – 12:10 PM PT
    2591: Under Assault: Ongoing Brain Dysfunction Identified on Resting State-functional MRI (rs-fMRI) in SLE Patients in Clinical Remission
    Location: Room 25A-C
    Systemic lupus erythematosus (SLE)
  • Wednesday, Nov 15th
    12:15 PM – 12:25 PM PT
    2592: Trends, Sociodemographic and Clinical Factors Associated with Avascular Necrosis and Related Arthroplasties in Hospitalized Patients with Systemic Lupus Erythematosus and Rheumatoid Arthritis
    Location: Room 25A-C
    Presenting Author: Rashmi Dhital, MD – UC San Diego
    Systemic lupus erythematosus (SLE)